☰

Bernard Moss - Publications

Affiliations: 
Cell Biology & Molecular Genetics University of Maryland, College Park, College Park, MD 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Zhu J, Gao X, Li Y, Zhang Z, Xie S, Ren S, Li Y, Li H, Niu K, Fu S, Deng Y, Li Y, Moss B, Wu W, Peng C. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1. Proceedings of the National Academy of Sciences of the United States of America. 120: e2304242120. PMID 37607234 DOI: 10.1073/pnas.2304242120  0.441
2023 Mutz P, Resch W, Faure G, Senkevich TG, Koonin EV, Moss B. Exaptation of Inactivated Host Enzymes for Structural Roles in Orthopoxviruses and Novel Folds of Virus Proteins Revealed by Protein Structure Modeling. Mbio. e0040823. PMID 37017580 DOI: 10.1128/mbio.00408-23  0.367
2023 Cotter CA, Americo JL, Earl PL, Moss B. Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice. Npj Vaccines. 8: 47. PMID 36973267 DOI: 10.1038/s41541-023-00645-7  0.315
2023 Americo JL, Earl PL, Moss B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proceedings of the National Academy of Sciences of the United States of America. 120: e2220415120. PMID 36787354 DOI: 10.1073/pnas.2220415120  0.312
2022 Priyamvada L, Kallemeijn WW, Faronato M, Wilkins K, Goldsmith CS, Cotter CA, Ojeda S, Solari R, Moss B, Tate EW, Satheshkumar PS. Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry. Plos Pathogens. 18: e1010662. PMID 36215331 DOI: 10.1371/journal.ppat.1010662  0.36
2021 Moss B, Smith GL. Research with variola virus after smallpox eradication: Development of a mouse model for variola virus infection. Plos Pathogens. 17: e1009911. PMID 34547026 DOI: 10.1371/journal.ppat.1009911  0.36
2021 Erez N, Wyatt LS, Americo JL, Xiao W, Moss B. Spontaneous and targeted mutations in the decapping enzyme enhance replication of modified vaccinia virus Ankara (MVA) in monkey cells. Journal of Virology. JVI0110421. PMID 34232734 DOI: 10.1128/JVI.01104-21  0.366
2021 Schin AM, Diesterbeck US, Moss B. Insights into the Organization of the Poxvirus Multi-Component Entry-Fusion Complex from Proximity Analyses in Living Infected Cells. Journal of Virology. JVI0085221. PMID 34076488 DOI: 10.1128/JVI.00852-21  0.331
2021 Liu R, Americo JL, Cotter CA, Earl PL, Erez N, Peng C, Moss B. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33688035 DOI: 10.1073/pnas.2026785118  0.347
2021 Tak AI, Americo JL, Diesterbeck US, Moss B. Loss of the vaccinia virus 35-amino acid hydrophobic O3 protein is partially compensated by mutations in the transmembrane domains of other entry proteins. Journal of Virology. PMID 33504600 DOI: 10.1128/JVI.02228-20  0.373
2021 Liu R, Americo JL, Cotter CA, Earl PL, Erez N, Peng C, Moss B. MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease. Biorxiv : the Preprint Server For Biology. PMID 33442693 DOI: 10.1101/2020.12.30.424878  0.319
2020 Martins MA, Gonzalez-Nieto L, Ricciardi MJ, Bailey VK, Dang CM, Bischof GF, Pedreño-Lopez N, Pauthner MG, Burton DR, Parks CL, Earl P, Moss B, Rakasz EG, Lifson JD, Desrosiers RC, et al. Rectal Acquisition of SIVmac239 Infection Despite Vaccine-Induced Immune Responses Against the Entire SIV Proteome. Journal of Virology. PMID 33028714 DOI: 10.1128/JVI.00979-20  0.368
2020 Peng C, Wyatt LS, Glushakow-Smith SG, Lal-Nag M, Weisberg AS, Moss B. Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells. Plos Pathogens. 16: e1008845. PMID 32866210 DOI: 10.1371/Journal.Ppat.1008845  0.541
2020 Senkevich TG, Zhivkoplias EK, Weisberg AS, Moss B. Inactivation of genes by frameshift mutations provides rapid adaptation of an attenuated vaccinia virus. Journal of Virology. PMID 32669330 DOI: 10.1128/Jvi.01053-20  0.435
2020 Moss B. Investigating Viruses During the Transformation of Molecular Biology: Part II. Annual Review of Virology. PMID 32392458 DOI: 10.1146/Annurev-Virology-021020-100558  0.393
2020 Earl PL, Americo JL, Moss B. Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses. Plos Pathogens. 16: e1008505. PMID 32320436 DOI: 10.1371/Journal.Ppat.1008505  0.349
2020 Cotter CA, Moss B. Mutations Near the N-Terminus of the Vaccinia Virus G9 Protein Overcome Restrictions on Cell Entry and Syncytium Formation Imposed by the A56/K2 Fusion Regulatory Complex. Journal of Virology. PMID 32132239 DOI: 10.1128/Jvi.00077-20  0.403
2020 Peng C, Moss B. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 32019881 DOI: 10.1073/Pnas.1921098117  0.503
2019 Katsafanas GC, Moss B. Specific Anchoring and Local Translation of Poxviral ATI mRNA at Cytoplasmic Inclusion Bodies. Journal of Virology. PMID 31776279 DOI: 10.1128/Jvi.01671-19  0.374
2019 Liu R, Olano LR, Mirzakhanyan Y, Gershon PD, Moss B. Vaccinia Virus Ankyrin-Repeat/F-Box Protein Targets Interferon-Induced IFITs for Proteasomal Degradation. Cell Reports. 29: 816-828.e6. PMID 31644906 DOI: 10.1016/J.Celrep.2019.09.039  0.471
2019 Liu R, Mendez-Rios JD, Peng C, Xiao W, Weisberg AS, Wyatt LS, Moss B. SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells. Plos Pathogens. 15: e1007710. PMID 31145755 DOI: 10.1371/Journal.Ppat.1007710  0.499
2019 Jones AT, Shen X, Walter KL, LaBranche CC, Wyatt LS, Tomaras GD, Montefiori DC, Moss B, Barouch DH, Clements JD, Kozlowski PA, Varadarajan R, Amara RR. HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge. Nature Communications. 10: 798. PMID 30778066 DOI: 10.1038/S41467-019-08739-4  0.364
2018 Chea LS, Wyatt LS, Gangadhara S, Moss B, Amara RR. Novel MVA Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses. Journal of Virology. PMID 30541829 DOI: 10.1128/Jvi.01648-18  0.405
2018 Diesterbeck US, Gittis AG, Garboczi DN, Moss B. The 2.1 Å structure of protein F9 and its comparison to L1, two components of the conserved poxvirus entry-fusion complex. Scientific Reports. 8: 16807. PMID 30429486 DOI: 10.1038/S41598-018-34244-7  0.324
2018 Sivan G, Glushakow-Smith SG, Katsafanas GC, Americo JL, Moss B. Human host-range restriction of the vaccinia virus C7/K1 double deletion mutant is mediated by an atypical mode of translation inhibition. Journal of Virology. PMID 30209174 DOI: 10.1128/Jvi.01329-18  0.478
2018 Stuart CA, Zhivkoplias EK, Senkevich TG, Wyatt LS, Moss B. RNA polymerase mutations selected during experimental evolution enhance replication of a hybrid vaccinia virus with an intermediate transcription factor subunit replaced by the myxoma virus ortholog. Journal of Virology. PMID 30045995 DOI: 10.1128/Jvi.01089-18  0.47
2018 Hu X, Valentin A, Cai Y, Dayton F, Rosati M, Ramirez-Salazar EG, Kulkarni V, Broderick KE, Sardesai NY, Wyatt LS, Earl PL, Moss B, Mullins JI, Pavlakis GN, Felber BK. DNA-vaccine induced long-lasting cytotoxic T cells targeting conserved elements of HIV Gag are boosted upon DNA or rMVA vaccination. Human Gene Therapy. PMID 29869530 DOI: 10.1089/Hum.2018.065  0.356
2018 Liu R, Moss B. Vaccinia virus C9 ankyrin-repeat/F-box protein is a newly identified antagonist of the type I interferon-induced antiviral state. Journal of Virology. PMID 29444943 DOI: 10.1128/Jvi.00053-18  0.518
2018 Liu B, Panda D, Mendez-Rios JD, Ganesan S, Wyatt LS, Moss B. Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant Roles. Journal of Virology. PMID 29343579 DOI: 10.1128/Jvi.02152-17  0.455
2017 Gangadhara S, Kwon YM, Jeeva S, Quan FS, Wang B, Moss B, Compans RW, Amara RR, Jabbar MA, Kang SM. Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins. Vaccines. 5. PMID 29257056 DOI: 10.3390/Vaccines5040052  0.444
2017 Jones AT, Chamcha V, Kesavardhana S, Shen X, Beaumont D, Das R, Wyatt LS, LaBranche CC, Stanfield-Oakley S, Ferrari G, Montefiori DC, Moss B, Tomaras GD, Varadarajan R, Amara RR. A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques. Journal of Virology. PMID 29237847 DOI: 10.1128/Jvi.01796-17  0.372
2017 Weisberg AS, Maruri-Avidal L, Bisht H, Hansen BT, Schwartz CL, Fischer ER, Meng X, Xiang Y, Moss B. Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutants. Proceedings of the National Academy of Sciences of the United States of America. PMID 29203656 DOI: 10.1073/Pnas.1716255114  0.461
2017 Sivan G, Ormanoglu P, Buehler EC, Martin SE, Moss B. Erratum for Sivan et al., "Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L(-)C7L(-) Mutant". Mbio. 8. PMID 29089434 DOI: 10.1128/Mbio.01735-17  0.385
2017 Shen X, Basu R, Sawant S, Beaumont D, Kwa SF, LaBranche C, Seaton KE, Yates NL, Montefiori DC, Ferrari G, Wyatt LS, Moss B, Alam SM, Haynes BF, Tomaras GD, et al. HIV-1 gp120 Protein and MVAgp140 Boost Immunogens Increase immunogenicity of a DNA/MVA HIV-1 Vaccine. Journal of Virology. PMID 29021394 DOI: 10.1128/Jvi.01077-17  0.41
2017 Americo JL, Earl PL, Moss B. Droplet digital PCR for rapid enumeration of viral genomes and particles from cells and animals infected with orthopoxviruses. Virology. 511: 19-22. PMID 28802157 DOI: 10.1016/J.Virol.2017.08.005  0.415
2017 Cotter CA, Earl PL, Wyatt LS, Moss B. Preparation of Cell Cultures and Vaccinia Virus Stocks. Current Protocols in Protein Science. 89: 5.12.1-5.12.18. PMID 28762495 DOI: 10.1002/cpps.34  0.402
2017 Wyatt LS, Earl PL, Moss B. Generation of Recombinant Vaccinia Viruses. Current Protocols in Protein Science. 89: 5.13.1-5.13.18. PMID 28762491 DOI: 10.1002/cpps.33  0.391
2017 Earl PL, Americo JL, Moss B. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection. Journal of Virology. PMID 28747505 DOI: 10.1128/Jvi.01042-17  0.445
2017 Senkevich TG, Katsafanas G, Weisberg A, Olano LR, Moss B. Identification of Vaccinia Virus Replisome and Transcriptome Proteins by iPOND Coupled with Mass Spectrometry. Journal of Virology. PMID 28747503 DOI: 10.1128/Jvi.01015-17  0.429
2017 Hinkula J, Petkov S, Ljungberg K, Hallengärd D, Bråve A, Isaguliants M, Falkeborn T, Sharma S, Liakina V, Robb M, Eller M, Moss B, Biberfeld G, Sandström E, Nilsson C, et al. HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV. Heliyon. 3: e00339. PMID 28721397 DOI: 10.1016/J.Heliyon.2017.E00339  0.324
2017 Wyatt LS, Xiao W, Americo JL, Earl PL, Moss B. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins. Mbio. 8. PMID 28588133 DOI: 10.1128/Mbio.00790-17  0.49
2017 Hyun SI, Weisberg A, Moss B. Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins. Journal of Virology. PMID 28490596 DOI: 10.1128/Jvi.00558-17  0.502
2017 Panda D, Fernandez DJ, Lal M, Buehler E, Moss B. Triad of human cellular proteins, IRF2, FAM111A, and RFC3, restrict replication of orthopoxvirus SPI-1 host-range mutants. Proceedings of the National Academy of Sciences of the United States of America. PMID 28320935 DOI: 10.1073/Pnas.1700678114  0.488
2017 Moss B. Investigating Viruses During the Transformation of Molecular Biology. The Journal of Biological Chemistry. PMID 28154190 DOI: 10.1074/Jbc.X117.778712  0.443
2017 Cotter CA, Earl PL, Wyatt LS, Moss B. Preparation of Cell Cultures and Vaccinia Virus Stocks. Current Protocols in Molecular Biology. 117: 16.16.1-16.16.18. PMID 28060410 DOI: 10.1002/cpmb.33  0.402
2017 Wyatt LS, Earl PL, Moss B. Generation of Recombinant Vaccinia Viruses. Current Protocols in Molecular Biology. 117: 16.17.1-16.17.18. PMID 28060405 DOI: 10.1002/cpmb.32  0.391
2016 Joachim A, Munseri PJ, Nilsson C, Bakari M, Aboud S, Lyamuya EF, Tecleab T, Liakina V, Scarlatti G, Robb M, Earl P, Moss B, Wahren B, Mhalu F, Ferarri G, et al. Three-year durability of immune responses induced by HIV-DNA and HIV-modified vaccinia virus Ankara and effect of a late HIV-MVA boost in Tanzanian volunteers. Aids Research and Human Retroviruses. PMID 28027665 DOI: 10.1089/Aid.2016.0251  0.326
2016 Reynolds SE, Earl PL, Minai M, Moore I, Moss B. A homolog of the variola virus B22 membrane protein contributes to ectromelia virus pathogenicity in the mouse footpad model. Virology. 501: 107-114. PMID 27898336 DOI: 10.1016/J.Virol.2016.11.010  0.535
2016 Kannanganat S, Wyatt LS, Gangadhara S, Chamcha V, Chea LS, Kozlowski PA, LaBranche CC, Chennareddi L, Lawson B, Reddy PB, Styles TM, Vanderford TH, Montefiori DC, Moss B, Robinson HL, et al. High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques. Journal of Immunology (Baltimore, Md. : 1950). PMID 27683750 DOI: 10.4049/Jimmunol.1600629  0.436
2016 Iyer SS, Gangadhara S, Victor B, Shen X, Chen X, Nabi R, Kasturi SP, Sabula MJ, Labranche CC, Reddy PJ, Tomaras GD, Montefiori DC, Moss B, Spearman P, Pulendran B, et al. Virus-like particles displaying trimeric SIV envelope gp160 enhance the breadth of DNA/MVA SIV vaccine induced antibody responses in rhesus macaques. Journal of Virology. PMID 27466414 DOI: 10.1128/Jvi.01163-16  0.447
2016 Sivan G, Weisberg AS, Americo JL, Moss B. Retrograde Transport from Early Endosomes to the Trans-Golgi Network Enables Membrane Wrapping and Egress of Vaccinia Virions. Journal of Virology. PMID 27466413 DOI: 10.1128/Jvi.01114-16  0.447
2016 Moss B. Membrane Fusion During Poxvirus Entry. Seminars in Cell & Developmental Biology. PMID 27423915 DOI: 10.1016/J.Semcdb.2016.07.015  0.503
2016 Liu R, Moss B. Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR/Cas9 Knock-Out Cell Lines and Vaccinia Virus Mutants. Journal of Virology. PMID 27334583 DOI: 10.1128/Jvi.00869-16  0.465
2016 Chamcha V, Kannanganat S, Gangadhara S, Nabi R, Kozlowski PA, Montefiori DC, LaBranche CC, Wrammert J, Keele BF, Balachandran H, Sahu S, Lifton M, Santra S, Basu R, Moss B, et al. Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine. Open Forum Infectious Diseases. 3: ofw034. PMID 27006959 DOI: 10.1093/Ofid/Ofw034  0.443
2016 Erlandson KJ, Bisht H, Weisberg AS, Hyun SI, Hansen BT, Fischer ER, Hinshaw JE, Moss B. Poxviruses Encode a Reticulon-Like Protein that Promotes Membrane Curvature. Cell Reports. PMID 26923595 DOI: 10.1016/J.Celrep.2016.01.075  0.421
2016 Mendez-Rios JD, Yang Z, Erlandson KJ, Cohen JI, Martens CA, Bruno DP, Porcella SF, Moss B. Molluscum Contagiosum Virus Transcriptome in Abortively Infected Cultured Cells and Human Skin Lesion. Journal of Virology. PMID 26889040 DOI: 10.1128/Jvi.02911-15  0.41
2015 Wyatt LS, Earl PL, Moss B. Generation of Recombinant Vaccinia Viruses. Current Protocols in Microbiology. 39: 14A.4.1-14A.4.18. PMID 26528782 DOI: 10.1002/9780471729259.mc14a04s39  0.391
2015 Cotter CA, Earl PL, Wyatt LS, Moss B. Preparation of Cell Cultures and Vaccinia Virus Stocks. Current Protocols in Microbiology. 39: 14A.3.1-14A.3.18. PMID 26528781 DOI: 10.1002/9780471729259.mc14a03s39  0.403
2015 Senkevich TG, Bruno D, Martens C, Porcella SF, Wolf YI, Moss B. Mapping vaccinia virus DNA replication origins at nucleotide level by deep sequencing. Proceedings of the National Academy of Sciences of the United States of America. 112: 10908-13. PMID 26286988 DOI: 10.1073/Pnas.1514809112  0.414
2015 Sivan G, Ormanoglu P, Buehler EC, Martin SE, Moss B. Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant. Mbio. 6. PMID 26242627 DOI: 10.1128/Mbio.01122-15  0.488
2015 Gjessing MC, Yutin N, Tengs T, Senkevich T, Koonin E, Rønning HP, Alarcon M, Ylving S, Lie KI, Saure B, Tran L, Moss B, Dale OB. Salmon Gill Poxvirus, the Deepest Representative of the Chordopoxvirinae. Journal of Virology. 89: 9348-67. PMID 26136578 DOI: 10.1128/Jvi.01174-15  0.456
2015 Iyer SS, Gangadhara S, Victor B, Gomez R, Basu R, Hong JJ, Labranche C, Montefiori DC, Villinger F, Moss B, Amara RR. Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus Macaques. Journal of Immunology (Baltimore, Md. : 1950). PMID 26116502 DOI: 10.4049/Jimmunol.1500083  0.378
2015 Reynolds SE, Moss B. Characterization of a large, proteolytically processed cowpox virus membrane glycoprotein conserved in most chordopoxviruses. Virology. 483: 209-17. PMID 25980741 DOI: 10.1016/J.Virol.2015.04.014  0.507
2015 Yang Z, Cao S, Martens CA, Porcella SF, Xie Z, Ma M, Shen B, Moss B. Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling. Journal of Virology. 89: 6874-86. PMID 25903347 DOI: 10.1128/Jvi.00528-15  0.375
2015 Munseri PJ, Kroidl A, Nilsson C, Joachim A, Geldmacher C, Mann P, Moshiro C, Aboud S, Lyamuya E, Maboko L, Missanga M, Kaluwa B, Mfinanga S, Podola L, Bauer A, ... ... Moss B, et al. Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial. Plos One. 10: e0119629. PMID 25875843 DOI: 10.1371/Journal.Pone.0119629  0.303
2015 Joachim A, Nilsson C, Aboud S, Bakari M, Lyamuya EF, Robb ML, Marovich MA, Earl P, Moss B, Ochsenbauer C, Wahren B, Mhalu F, Sandström E, Biberfeld G, Ferrari G, et al. Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults. Plos One. 10: e0118486. PMID 25874723 DOI: 10.1371/Journal.Pone.0118486  0.351
2015 Earl PL, Americo JL, Moss B. Genetic studies of the susceptibility of classical and wild-derived inbred mouse strains to monkeypox virus. Virology. 481: 161-5. PMID 25791934 DOI: 10.1016/J.Virol.2015.02.048  0.307
2015 Liu SW, Katsafanas GC, Liu R, Wyatt LS, Moss B. Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses. Cell Host & Microbe. 17: 320-31. PMID 25766293 DOI: 10.1016/J.Chom.2015.02.002  0.447
2015 Hyun SI, Maruri-Avidal L, Moss B. Topology of Endoplasmic Reticulum-Associated Cellular and Viral Proteins Determined with Split-GFP. Traffic (Copenhagen, Denmark). 16: 787-95. PMID 25761760 DOI: 10.1111/Tra.12281  0.397
2015 Moss B. Poxvirus membrane biogenesis. Virology. 479: 619-26. PMID 25728299 DOI: 10.1016/J.Virol.2015.02.003  0.407
2015 Kwa S, Sadagopal S, Shen X, Hong JJ, Gangadhara S, Basu R, Victor B, Iyer SS, LaBranche CC, Montefiori DC, Tomaras GD, Villinger F, Moss B, Kozlowski PA, Amara RR. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection. Journal of Virology. 89: 4690-5. PMID 25653428 DOI: 10.1128/Jvi.03527-14  0.494
2015 Earl PL, Americo JL, Cotter CA, Moss B. Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African dormouse (Graphiurus kelleni). Virology. 475: 150-8. PMID 25462355 DOI: 10.1016/J.Virol.2014.11.015  0.484
2014 Erlandson KJ, Cotter CA, Charity JC, Martens C, Fischer ER, Ricklefs SM, Porcella SF, Moss B. Duplication of the A17L locus of vaccinia virus provides an alternate route to rifampin resistance. Journal of Virology. 88: 11576-85. PMID 25078687 DOI: 10.1128/Jvi.00618-14  0.461
2014 Laliberte JP, Moss B. A novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes. Journal of Virology. 88: 9751-68. PMID 24920806 DOI: 10.1128/Jvi.00816-14  0.527
2014 Kwa S, Lai L, Gangadhara S, Siddiqui M, Pillai VB, Labranche C, Yu T, Moss B, Montefiori DC, Robinson HL, Kozlowski PA, Amara RR. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge. Journal of Virology. 88: 9579-89. PMID 24920805 DOI: 10.1128/Jvi.00975-14  0.464
2014 Kastenmayer RJ, Maruri-Avidal L, Americo JL, Earl PL, Weisberg AS, Moss B. Elimination of A-type inclusion formation enhances cowpox virus replication in mice: implications for orthopoxvirus evolution. Virology. 452: 59-66. PMID 24606683 DOI: 10.1016/J.Virol.2013.12.030  0.52
2014 Americo JL, Sood CL, Cotter CA, Vogel JL, Kristie TM, Moss B, Earl PL. Susceptibility of the wild-derived inbred CAST/Ei mouse to infection by orthopoxviruses analyzed by live bioluminescence imaging. Virology. 449: 120-32. PMID 24418545 DOI: 10.1016/J.Virol.2013.11.017  0.791
2014 Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, DeRosa SC, Kalams SA, McElrath MJ, Keefer MC, Baden LR, Lama JR, Sanchez J, Mulligan MJ, ... ... Moss B, et al. Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. The Journal of Infectious Diseases. 210: 99-110. PMID 24403557 DOI: 10.1093/Infdis/Jiu003  0.427
2014 Liu SW, Wyatt LS, Orandle MS, Minai M, Moss B. The D10 decapping enzyme of vaccinia virus contributes to decay of cellular and viral mRNAs and to virulence in mice. Journal of Virology. 88: 202-11. PMID 24155373 DOI: 10.1128/Jvi.02426-13  0.489
2013 Barouch DH, Stephenson KE, Borducchi EN, Smith K, Stanley K, McNally AG, Liu J, Abbink P, Maxfield LF, Seaman MS, Dugast AS, Alter G, Ferguson M, Li W, Earl PL, ... Moss B, et al. Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell. 155: 531-9. PMID 24243013 DOI: 10.1016/J.Cell.2013.09.061  0.346
2013 Yang Z, Maruri-Avidal L, Sisler J, Stuart CA, Moss B. Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters. Virology. 447: 213-20. PMID 24210117 DOI: 10.1016/J.Virol.2013.09.007  0.408
2013 Maruri-Avidal L, Weisberg AS, Moss B. Direct formation of vaccinia virus membranes from the endoplasmic reticulum in the absence of the newly characterized L2-interacting protein A30.5. Journal of Virology. 87: 12313-26. PMID 24027302 DOI: 10.1128/Jvi.02137-13  0.419
2013 Melamed S, Wyatt LS, Kastenmayer RJ, Moss B. Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants. Vaccine. 31: 4569-77. PMID 23928462 DOI: 10.1016/J.Vaccine.2013.07.057  0.417
2013 Satheshkumar PS, Olano LR, Hammer CH, Zhao M, Moss B. Interactions of the vaccinia virus A19 protein. Journal of Virology. 87: 10710-20. PMID 23885084 DOI: 10.1128/Jvi.01261-13  0.471
2013 Satheshkumar PS, Weisberg AS, Moss B. Vaccinia virus A19 protein participates in the transformation of spherical immature particles to barrel-shaped infectious virions. Journal of Virology. 87: 10700-9. PMID 23885081 DOI: 10.1128/Jvi.01258-13  0.449
2013 Maruri-Avidal L, Weisberg AS, Moss B. Association of the vaccinia virus A11 protein with the endoplasmic reticulum and crescent precursors of immature virions. Journal of Virology. 87: 10195-206. PMID 23864611 DOI: 10.1128/Jvi.01601-13  0.426
2013 Moss B. Poxvirus DNA replication. Cold Spring Harbor Perspectives in Biology. 5. PMID 23838441 DOI: 10.1101/Cshperspect.A010199  0.381
2013 Satheshkumar PS, Chavre J, Moss B. Role of the vaccinia virus O3 protein in cell entry can be fulfilled by its Sequence flexible transmembrane domain. Virology. 444: 148-57. PMID 23816434 DOI: 10.1016/J.Virol.2013.06.003  0.416
2013 Dong B, Moore AR, Dai J, Roberts S, Chu K, Kapranov P, Moss B, Xiao W. A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy. Nucleic Acids Research. 41: 6609-17. PMID 23677609 DOI: 10.1093/Nar/Gkt404  0.409
2013 Moss B. Reflections on the early development of poxvirus vectors. Vaccine. 31: 4220-2. PMID 23583893 DOI: 10.1016/J.Vaccine.2013.03.042  0.351
2013 Sivan G, Martin SE, Myers TG, Buehler E, Szymczyk KH, Ormanoglu P, Moss B. Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Proceedings of the National Academy of Sciences of the United States of America. 110: 3519-24. PMID 23401514 DOI: 10.1073/Pnas.1300708110  0.437
2013 Helenius A, Moss B. Virus entry--an unwilling collaboration by the cell. Current Opinion in Virology. 3: 1-2. PMID 23395460 DOI: 10.1016/J.Coviro.2013.01.003  0.439
2013 Quinn KM, Da Costa A, Yamamoto A, Berry D, Lindsay RW, Darrah PA, Wang L, Cheng C, Kong WP, Gall JG, Nicosia A, Folgori A, Colloca S, Cortese R, Gostick E, ... ... Moss B, et al. Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization. Journal of Immunology (Baltimore, Md. : 1950). 190: 2720-35. PMID 23390298 DOI: 10.4049/Jimmunol.1202861  0.318
2013 Maruri-Avidal L, Weisberg AS, Bisht H, Moss B. Analysis of viral membranes formed in cells infected by a vaccinia virus L2-deletion mutant suggests their origin from the endoplasmic reticulum. Journal of Virology. 87: 1861-71. PMID 23192873 DOI: 10.1128/Jvi.02779-12  0.431
2012 Ratto-Kim S, Currier JR, Cox JH, Excler JL, Valencia-Micolta A, Thelian D, Lo V, Sayeed E, Polonis VR, Earl PL, Moss B, Robb ML, Michael NL, Kim JH, Marovich MA. Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens. Plos One. 7: e45840. PMID 23049876 DOI: 10.1371/Journal.Pone.0045840  0.358
2012 Hallengärd D, Applequist SE, Nyström S, Maltais AK, Marovich M, Moss B, Earl P, Nihlmark K, Wahren B, Bråve A. Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses. Viral Immunology. 25: 423-32. PMID 23035853 DOI: 10.1089/Vim.2012.0046  0.36
2012 Bengali Z, Satheshkumar PS, Moss B. Orthopoxvirus species and strain differences in cell entry. Virology. 433: 506-12. PMID 22999097 DOI: 10.1016/J.Virol.2012.08.044  0.447
2012 Backes S, Shapiro JS, Sabin LR, Pham AM, Reyes I, Moss B, Cherry S, tenOever BR. Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism. Cell Host & Microbe. 12: 200-10. PMID 22901540 DOI: 10.1016/J.Chom.2012.05.019  0.324
2012 Yang Z, Martens CA, Bruno DP, Porcella SF, Moss B. Pervasive initiation and 3'-end formation of poxvirus postreplicative RNAs. The Journal of Biological Chemistry. 287: 31050-60. PMID 22829601 DOI: 10.1074/Jbc.M112.390054  0.351
2012 Moss B. Poxvirus cell entry: how many proteins does it take? Viruses. 4: 688-707. PMID 22754644 DOI: 10.3390/V4050688  0.445
2012 Warren RD, Cotter CA, Moss B. Reverse genetics analysis of poxvirus intermediate transcription factors. Journal of Virology. 86: 9514-9. PMID 22740406 DOI: 10.1128/Jvi.06902-11  0.4
2012 Earl PL, Americo JL, Moss B. Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response. Journal of Virology. 86: 9105-12. PMID 22696658 DOI: 10.1128/Jvi.00162-12  0.383
2012 Mendez-Rios JD, Martens CA, Bruno DP, Porcella SF, Zheng ZM, Moss B. Genome sequence of erythromelalgia-related poxvirus identifies it as an ectromelia virus strain. Plos One. 7: e34604. PMID 22558090 DOI: 10.1371/Journal.Pone.0034604  0.392
2012 Howard AR, Moss B. Formation of orthopoxvirus cytoplasmic A-type inclusion bodies and embedding of virions are dynamic processes requiring microtubules. Journal of Virology. 86: 5905-14. PMID 22438543 DOI: 10.1128/Jvi.06997-11  0.471
2012 Cox JH, Ferrari MG, Earl P, Lane JR, Jagodzinski LL, Polonis VR, Kuta EG, Boyer JD, Ratto-Kim S, Eller LA, Pham DT, Hart L, Montefiori D, Ferrari G, Parrish S, ... ... Moss B, et al. Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge. Vaccine. 30: 1830-40. PMID 22234262 DOI: 10.1016/J.Vaccine.2011.12.131  0.419
2012 Lai L, Kwa SF, Kozlowski PA, Montefiori DC, Nolen TL, Hudgens MG, Johnson WE, Ferrari G, Hirsch VM, Felber BK, Pavlakis GN, Earl PL, Moss B, Amara RR, Robinson HL. SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses. Vaccine. 30: 1737-45. PMID 22178526 DOI: 10.1016/J.Vaccine.2011.12.026  0.388
2012 Wang Z, Lai Y, Bernard JJ, Macleod DT, Cogen AL, Moss B, Di Nardo A. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides. Journal of Immunology (Baltimore, Md. : 1950). 188: 345-57. PMID 22140255 DOI: 10.4049/Jimmunol.1101703  0.375
2012 Satheshkumar PS, Moss B. Sequence-divergent chordopoxvirus homologs of the o3 protein maintain functional interactions with components of the vaccinia virus entry-fusion complex. Journal of Virology. 86: 1696-705. PMID 22114343 DOI: 10.1128/Jvi.06069-11  0.354
2012 Wolfe CL, Ojeda S, Moss B. Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex. Journal of Virology. 86: 293-301. PMID 22013036 DOI: 10.1128/Jvi.05935-11  0.509
2011 Laliberte JP, Weisberg AS, Moss B. The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components. Plos Pathogens. 7: e1002446. PMID 22194690 DOI: 10.1371/Journal.Ppat.1002446  0.47
2011 Maruri-Avidal L, Weisberg AS, Moss B. Vaccinia virus L2 protein associates with the endoplasmic reticulum near the growing edge of crescent precursors of immature virions and stabilizes a subset of viral membrane proteins. Journal of Virology. 85: 12431-41. PMID 21917978 DOI: 10.1128/Jvi.05573-11  0.437
2011 Yang Z, Reynolds SE, Martens CA, Bruno DP, Porcella SF, Moss B. Expression profiling of the intermediate and late stages of poxvirus replication. Journal of Virology. 85: 9899-908. PMID 21795349 DOI: 10.1128/Jvi.05446-11  0.435
2011 Senkevich TG, Koonin EV, Moss B. Vaccinia virus F16 protein, a predicted catalytically inactive member of the prokaryotic serine recombinase superfamily, is targeted to nucleoli. Virology. 417: 334-42. PMID 21752417 DOI: 10.1016/J.Virol.2011.06.017  0.423
2011 Lai L, Kwa S, Kozlowski PA, Montefiori DC, Ferrari G, Johnson WE, Hirsch V, Villinger F, Chennareddi L, Earl PL, Moss B, Amara RR, Robinson HL. Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine. The Journal of Infectious Diseases. 204: 164-73. PMID 21628671 DOI: 10.1093/Infdis/Jir199  0.433
2011 Yang Z, Bruno DP, Martens CA, Porcella SF, Moss B. Genome-wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts. Journal of Virology. 85: 5897-909. PMID 21490097 DOI: 10.1128/Jvi.00428-11  0.392
2011 Marthas ML, Van Rompay KK, Abbott Z, Earl P, Buonocore-Buzzelli L, Moss B, Rose NF, Rose JK, Kozlowski PA, Abel K. Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques. Vaccine. 29: 3124-37. PMID 21377510 DOI: 10.1016/J.Vaccine.2011.02.051  0.415
2011 Bengali Z, Satheshkumar PS, Yang Z, Weisberg AS, Paran N, Moss B. Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcription. Plos One. 6: e17248. PMID 21347205 DOI: 10.1371/Journal.Pone.0017248  0.498
2011 Wolfe CL, Moss B. Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex. Virology. 412: 278-83. PMID 21295816 DOI: 10.1016/J.Virol.2011.01.014  0.405
2011 Goepfert PA, Elizaga ML, Sato A, Qin L, Cardinali M, Hay CM, Hural J, DeRosa SC, DeFawe OD, Tomaras GD, Montefiori DC, Xu Y, Lai L, Kalams SA, Baden LR, ... ... Moss B, et al. Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. The Journal of Infectious Diseases. 203: 610-9. PMID 21282192 DOI: 10.1093/Infdis/Jiq105  0.362
2011 Maruri-Avidal L, Domi A, Weisberg AS, Moss B. Participation of vaccinia virus l2 protein in the formation of crescent membranes and immature virions. Journal of Virology. 85: 2504-11. PMID 21228235 DOI: 10.1128/Jvi.02505-10  0.42
2011 Moss B. Smallpox vaccines: targets of protective immunity. Immunological Reviews. 239: 8-26. PMID 21198662 DOI: 10.1111/J.1600-065X.2010.00975.X  0.381
2011 Newman MJ, Robinson HL, Lai L, Chennareddi L, Kwa S, Villinger F, Montefiori D, Kozlowski P, Wyatt LS, Earl P, Moss B, Amara RR. 140 Induction of Efficacious Immune Responses Using Heterologous Prime: Boost Regimens of Recombinant DNA and MVA Vectored HIV Vaccines and GM-CSF as the Adjuvant Jaids Journal of Acquired Immune Deficiency Syndromes. 56: 57. DOI: 10.1097/01.Qai.0000397326.26622.15  0.327
2011 Viard M, Moss B, Blumenthal R. Mechanisms of Entry of Vaccinia Virus into Cells Studied by Photosensitized Labeling Biophysical Journal. 100: 632a. DOI: 10.1016/j.bpj.2010.12.3634  0.34
2010 Laliberte JP, Moss B. Lipid membranes in poxvirus replication. Viruses. 2: 972-86. PMID 21994664 DOI: 10.3390/V2040972  0.336
2010 Currier JR, Ngauy V, de Souza MS, Ratto-Kim S, Cox JH, Polonis VR, Earl P, Moss B, Peel S, Slike B, Sriplienchan S, Thongcharoen P, Paris RM, Robb ML, Kim J, et al. Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate. Plos One. 5: e13983. PMID 21085591 DOI: 10.1371/Journal.Pone.0013983  0.331
2010 Kannanganat S, Nigam P, Velu V, Earl PL, Lai L, Chennareddi L, Lawson B, Wilson RL, Montefiori DC, Kozlowski PA, Moss B, Robinson HL, Amara RR. Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine. Journal of Immunology (Baltimore, Md. : 1950). 185: 7262-73. PMID 21076059 DOI: 10.4049/Jimmunol.1000751  0.452
2010 Shinoda K, Wyatt LS, Moss B. The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein. Virology. 405: 41-9. PMID 20673745 DOI: 10.1016/J.Virol.2010.05.025  0.408
2010 Yang Z, Bruno DP, Martens CA, Porcella SF, Moss B. Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proceedings of the National Academy of Sciences of the United States of America. 107: 11513-8. PMID 20534518 DOI: 10.1073/Pnas.1006594107  0.43
2010 Americo JL, Moss B, Earl PL. Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models. Journal of Virology. 84: 8172-80. PMID 20519404 DOI: 10.1128/Jvi.00621-10  0.4
2010 Howard AR, Weisberg AS, Moss B. Congregation of orthopoxvirus virions in cytoplasmic A-type inclusions is mediated by interactions of a bridging protein (A26p) with a matrix protein (ATIp) and a virion membrane-associated protein (A27p). Journal of Virology. 84: 7592-602. PMID 20484506 DOI: 10.1128/Jvi.00704-10  0.387
2010 Koonin EV, Moss B. Viruses know more than one way to don a cap. Proceedings of the National Academy of Sciences of the United States of America. 107: 3283-4. PMID 20167804 DOI: 10.1073/Pnas.0915061107  0.4
2010 Bisht H, Brown E, Moss B. Kinetics and intracellular location of intramolecular disulfide bond formation mediated by the cytoplasmic redox system encoded by vaccinia virus. Virology. 398: 187-93. PMID 20042211 DOI: 10.1016/J.Virol.2009.11.026  0.356
2010 Van Rompay KK, Abel K, Earl P, Kozlowski PA, Easlick J, Moore J, Buonocore-Buzzelli L, Schmidt KA, Wilson RL, Simon I, Moss B, Rose N, Rose J, Marthas ML. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV. Vaccine. 28: 1481-92. PMID 19995539 DOI: 10.1016/J.Vaccine.2009.11.061  0.412
2010 Sood CL, Moss B. Vaccinia virus A43R gene encodes an orthopoxvirus-specific late non-virion type-1 membrane protein that is dispensable for replication but enhances intradermal lesion formation Virology. 396: 160-168. PMID 19900687 DOI: 10.1016/J.Virol.2009.10.025  0.819
2009 Paran N, De Silva FS, Senkevich TG, Moss B. Cellular DNA ligase I is recruited to cytoplasmic vaccinia virus factories and masks the role of the vaccinia ligase in viral DNA replication. Cell Host & Microbe. 6: 563-9. PMID 20006844 DOI: 10.1016/J.Chom.2009.11.005  0.461
2009 Satheshkumar PS, Moss B. Characterization of a newly identified 35-amino-acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses. Journal of Virology. 83: 12822-32. PMID 19812151 DOI: 10.1128/Jvi.01744-09  0.489
2009 Senkevich TG, Koonin EV, Moss B. Predicted poxvirus FEN1-like nuclease required for homologous recombination, double-strand break repair and full-size genome formation. Proceedings of the National Academy of Sciences of the United States of America. 106: 17921-6. PMID 19805122 DOI: 10.1073/Pnas.0909529106  0.485
2009 Laliberte JP, Moss B. Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry. Proceedings of the National Academy of Sciences of the United States of America. 106: 17517-21. PMID 19805093 DOI: 10.1073/Pnas.0909376106  0.46
2009 Yang Z, Moss B. Interaction of the vaccinia virus RNA polymerase-associated 94-kilodalton protein with the early transcription factor. Journal of Virology. 83: 12018-26. PMID 19759131 DOI: 10.1128/Jvi.01653-09  0.478
2009 Parrish S, Hurchalla M, Liu SW, Moss B. The African swine fever virus g5R protein possesses mRNA decapping activity. Virology. 393: 177-82. PMID 19695654 DOI: 10.1016/J.Virol.2009.07.026  0.393
2009 Earl PL, Cotter C, Moss B, VanCott T, Currier J, Eller LA, McCutchan F, Birx DL, Michael NL, Marovich MA, Robb M, Cox JH. Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines. Vaccine. 27: 5885-95. PMID 19654066 DOI: 10.1016/J.Vaccine.2009.07.039  0.38
2009 Bisht H, Weisberg AS, Szajner P, Moss B. Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis. Journal of Virology. 83: 9140-50. PMID 19570860 DOI: 10.1128/Jvi.00875-09  0.366
2009 Satheshkumar PS, Weisberg A, Moss B. Vaccinia virus H7 protein contributes to the formation of crescent membrane precursors of immature virions. Journal of Virology. 83: 8439-50. PMID 19553304 DOI: 10.1128/JVI.00877-09  0.346
2009 Gudmundsdotter L, Nilsson C, Brave A, Hejdeman B, Earl P, Moss B, Robb M, Cox J, Michael N, Marovich M, Biberfeld G, Sandström E, Wahren B. Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity. Vaccine. 27: 4468-74. PMID 19450644 DOI: 10.1016/J.Vaccine.2009.05.018  0.376
2009 Bengali Z, Townsley AC, Moss B. Vaccinia virus strain differences in cell attachment and entry. Virology. 389: 132-40. PMID 19428041 DOI: 10.1016/J.Virol.2009.04.012  0.342
2009 Wyatt LS, Earl PL, Xiao W, Americo JL, Cotter CA, Vogt J, Moss B. Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection. Journal of Virology. 83: 7176-84. PMID 19420086 DOI: 10.1128/Jvi.00687-09  0.488
2009 Shinoda K, Wyatt LS, Irvine KR, Moss B. Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization. Virology Journal. 6: 28. PMID 19257896 DOI: 10.1186/1743-422X-6-28  0.529
2009 Zhao J, Lai L, Amara RR, Montefiori DC, Villinger F, Chennareddi L, Wyatt LS, Moss B, Robinson HL. Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia. Journal of Virology. 83: 4102-11. PMID 19224993 DOI: 10.1128/Jvi.02173-08  0.416
2009 Resch W, Weisberg AS, Moss B. Expression of the highly conserved vaccinia virus E6 protein is required for virion morphogenesis. Virology. 386: 478-85. PMID 19217136 DOI: 10.1016/J.Virol.2009.01.009  0.522
2009 Schell J, Rose NF, Fazo N, Marx PA, Hunter M, Ramsburg E, Montefiori D, Earl P, Moss B, Rose JK. Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge. Vaccine. 27: 979-86. PMID 19135115 DOI: 10.1016/J.Vaccine.2008.12.017  0.45
2009 Satheshkumar PS, Anton LC, Sanz P, Moss B. Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes. Journal of Virology. 83: 2469-79. PMID 19129442 DOI: 10.1128/Jvi.01986-08  0.475
2009 Zhang L, Lee SY, Beznoussenko GV, Peters PJ, Yang JS, Gilbert HY, Brassd AL, Elledge SJ, Isaacs SN, Moss B, Mironov A, Hsu VW. A role for the host coatomer and KDEL receptor in early vaccinia biogenesis Proceedings of the National Academy of Sciences of the United States of America. 106: 163-168. PMID 19109439 DOI: 10.1073/Pnas.0811631106  0.441
2009 Wagenaar TR, Moss B. Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion. Journal of Virology. 83: 1546-54. PMID 19036815 DOI: 10.1128/Jvi.01684-08  0.397
2009 De Silva FS, Paran N, Moss B. Products and substrate/template usage of vaccinia virus DNA primase. Virology. 383: 136-41. PMID 19007959 DOI: 10.1016/J.Virol.2008.10.008  0.378
2009 Wyatt L, Earl P, Moss B. P19-52 LB. Assessing and restructuring foreign gene insertion sites for enhanced stability of modified Vaccinia virus ankara recombinants expressing HIV genes Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P416  0.352
2009 Kannanganat S, Nigam P, Velu V, Earl P, Lai L, Lawson B, Chennareddi L, Wilson R, Kozlowski P, Moss B, Robinson H, Amara R. OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge Retrovirology. 6: 1-1. DOI: 10.1186/1742-4690-6-S3-O51  0.3
2009 Currier J, Souza MD, Ratto-Kim S, Paris R, Nguay V, Cox J, Earl P, Moss B, Sriplienchan S, Thongcharoen P, Kim J, Robb M, Michael N, Marovich M. OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial Retrovirology. 6: 1-1. DOI: 10.1186/1742-4690-6-S3-O27  0.305
2008 De Silva FS, Moss B. Effects of vaccinia virus uracil DNA glycosylase catalytic site and deoxyuridine triphosphatase deletion mutations individually and together on replication in active and quiescent cells and pathogenesis in mice. Virology Journal. 5: 145. PMID 19055736 DOI: 10.1186/1743-422X-5-145  0.431
2008 Taub DD, Ershler WB, Janowski M, Artz A, Key ML, McKelvey J, Muller D, Moss B, Ferrucci L, Duffey PL, Longo DL. Immunity from smallpox vaccine persists for decades: a longitudinal study. The American Journal of Medicine. 121: 1058-64. PMID 19028201 DOI: 10.1016/J.Amjmed.2008.08.019  0.313
2008 Howard AR, Senkevich TG, Moss B. Vaccinia virus A26 and A27 proteins form a stable complex tethered to mature virions by association with the A17 transmembrane protein. Journal of Virology. 82: 12384-91. PMID 18842719 DOI: 10.1128/Jvi.01524-08  0.325
2008 Satheshkumar PS, Moss B. Poxvirus transcriptome analysis. Proceedings of the National Academy of Sciences of the United States of America. 105: E62; author reply E6. PMID 18832142 DOI: 10.1073/Pnas.0804594105  0.339
2008 Sandström E, Nilsson C, Hejdeman B, Bråve A, Bratt G, Robb M, Cox J, VanCott T, Marovich M, Stout R, Aboud S, Bakari M, Pallangyo K, Ljungberg K, Moss B, et al. Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara Journal of Infectious Diseases. 198: 1482-1490. PMID 18808335 DOI: 10.1086/592507  0.38
2008 Belyakov IM, Ahlers JD, Nabel GJ, Moss B, Berzofsky JA. Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization. Virology. 381: 106-15. PMID 18793787 DOI: 10.1016/J.Virol.2008.08.019  0.342
2008 Nelson GE, Sisler JR, Chandran D, Moss B. Vaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodies. Virology. 380: 394-401. PMID 18789472 DOI: 10.1016/J.Virol.2008.08.009  0.441
2008 Sood CL, Ward JM, Moss B. Vaccinia virus encodes i5, a small hydrophobic virion membrane protein that enhances replication and virulence in mice Journal of Virology. 82: 10071-10078. PMID 18701595 DOI: 10.1128/Jvi.01355-08  0.833
2008 Earl PL, Americo JL, Wyatt LS, Espenshade O, Bassler J, Gong K, Lin S, Peters E, Rhodes L, Spano YE, Silvera PM, Moss B. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proceedings of the National Academy of Sciences of the United States of America. 105: 10889-94. PMID 18678911 DOI: 10.1073/Pnas.0804985105  0.394
2008 Bisht H, Weisberg AS, Moss B. Vaccinia virus l1 protein is required for cell entry and membrane fusion. Journal of Virology. 82: 8687-94. PMID 18596103 DOI: 10.1128/Jvi.00852-08  0.474
2008 Fogg CN, Americo JL, Earl PL, Resch W, Aldaz-Carroll L, Eisenberg RJ, Cohen GH, Moss B. Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge. Journal of Virology. 82: 8022-9. PMID 18524827 DOI: 10.1128/Jvi.00568-08  0.693
2008 Elroy-Stein O, Moss B. Gene expression using the vaccinia virus/ T7 RNA polymerase hybrid system. Current Protocols in Protein Science. Unit5.15. PMID 18429181 DOI: 10.1002/0471140864.Ps0515S14  0.413
2008 Earl PL, Moss B. Characterization of recombinant vaccinia viruses and their products. Current Protocols in Protein Science. Unit5.14. PMID 18429180 DOI: 10.1002/0471140864.Ps0514S13  0.51
2008 Moss B, Earl PL. Overview of the vaccinia virus expression system. Current Protocols in Protein Science. Unit5.11. PMID 18429177 DOI: 10.1002/0471140864.Ps0511S13  0.518
2008 Nelson GE, Wagenaar TR, Moss B. A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity. Journal of Virology. 82: 6244-50. PMID 18417576 DOI: 10.1128/Jvi.00434-08  0.413
2008 Wagenaar TR, Ojeda S, Moss B. Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex. Journal of Virology. 82: 5153-60. PMID 18353946 DOI: 10.1128/Jvi.00162-08  0.329
2008 Domi A, Weisberg AS, Moss B. Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread. Journal of Virology. 82: 4215-26. PMID 18287229 DOI: 10.1128/JVI.00037-08  0.472
2008 Senkevich TG, Wyatt LS, Weisberg AS, Koonin EV, Moss B. A conserved poxvirus NlpC/P60 superfamily protein contributes to vaccinia virus virulence in mice but not to replication in cell culture. Virology. 374: 506-14. PMID 18281072 DOI: 10.1016/j.virol.2008.01.009  0.432
2008 Moss B, Earl PL. Overview of the vaccinia virus expression system. Current Protocols in Molecular Biology. Unit16.15. PMID 18265301 DOI: 10.1002/0471142727.Mb1615S60  0.518
2008 Earl PL, Moss B. Characterization of recombinant vaccinia viruses and their products. Current Protocols in Molecular Biology. Unit16.18. PMID 18265125 DOI: 10.1002/0471142727.mb1618s43  0.413
2008 Wyatt LS, Earl PL, Vogt J, Eller LA, Chandran D, Liu J, Robinson HL, Moss B. Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines. Vaccine. 26: 486-93. PMID 18155813 DOI: 10.1016/J.Vaccine.2007.11.036  0.43
2008 Wyatt LS, Belyakov IM, Earl PL, Berzofsky JA, Moss B. Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA. Virology. 372: 260-72. PMID 18048074 DOI: 10.1016/J.Virol.2007.10.033  0.42
2008 Davies DH, Wyatt LS, Newman FK, Earl PL, Chun S, Hernandez JE, Molina DM, Hirst S, Moss B, Frey SE, Felgner PL. Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. Journal of Virology. 82: 652-63. PMID 17977963 DOI: 10.1128/Jvi.01706-07  0.518
2008 Abel K, Van Rompay KK, Eastlick J, Moore J, Lemieux M, Schmidt K, Earl P, Buonocore-Buzzelli L, Moss B, Rose N, Rose J, McChesney MB, Kozlowski P, Marthas ML. VSV/MVA vaccine rapidly elicits SIV antibodies and local and systemic SIV T cell responses in macaque neonates but does not prevent SIV dissemination after oral challenge Retrovirology. 5: O15. DOI: 10.1186/1742-4690-5-S1-O15  0.332
2007 Bråve A, Boberg A, Gudmundsdotter L, Rollman E, Hallermalm K, Ljungberg K, Blomberg P, Stout R, Paulie S, Sandström E, Biberfeld G, Earl P, Moss B, Cox JH, Wahren B. A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8(+) T-cell and Humoral Responses in Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1724-1733. PMID 28182928 DOI: 10.1038/Sj.Mt.6300235  0.402
2007 Robinson HL, Sharma S, Zhao J, Kannanganat S, Lai L, Chennareddi L, Yu T, Montefiori DC, Amara RR, Wyatt LS, Moss B. Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cells. Aids Research and Human Retroviruses. 23: 1555-62. PMID 18160013 DOI: 10.1089/Aid.2007.0165  0.331
2007 Katsafanas GC, Moss B. Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions. Cell Host & Microbe. 2: 221-8. PMID 18005740 DOI: 10.1016/J.Chom.2007.08.005  0.518
2007 De Silva FS, Lewis W, Berglund P, Koonin EV, Moss B. Poxvirus DNA primase. Proceedings of the National Academy of Sciences of the United States of America. 104: 18724-9. PMID 18000036 DOI: 10.1073/Pnas.0709276104  0.465
2007 Kwissa M, Amara RR, Robinson HL, Moss B, Alkan S, Jabbar A, Villinger F, Pulendran B. Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. The Journal of Experimental Medicine. 204: 2733-46. PMID 17954572 DOI: 10.1084/Jem.20071211  0.383
2007 Hebben M, Brants J, Birck C, Samama JP, Wasylyk B, Spehner D, Pradeau K, Domi A, Moss B, Schultz P, Drillien R. High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara. Protein Expression and Purification. 56: 269-78. PMID 17892951 DOI: 10.1016/J.Pep.2007.08.003  0.524
2007 Parrish S, Moss B. Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses. Journal of Virology. 81: 12973-8. PMID 17881455 DOI: 10.1128/Jvi.01668-07  0.389
2007 Lai L, Vödrös D, Kozlowski PA, Montefiori DC, Wilson RL, Akerstrom VL, Chennareddi L, Yu T, Kannanganat S, Ofielu L, Villinger F, Wyatt LS, Moss B, Amara RR, Robinson HL. GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine. Virology. 369: 153-67. PMID 17698160 DOI: 10.1016/J.Virol.2007.07.017  0.387
2007 Chen Z, Earl P, Americo J, Damon I, Smith SK, Yu F, Sebrell A, Emerson S, Cohen G, Eisenberg RJ, Gorshkova I, Schuck P, Satterfield W, Moss B, Purcell R. Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model. Journal of Virology. 81: 8989-95. PMID 17581986 DOI: 10.1128/Jvi.00906-07  0.444
2007 Townsley AC, Moss B. Two distinct low-pH steps promote entry of vaccinia virus. Journal of Virology. 81: 8613-20. PMID 17553884 DOI: 10.1128/Jvi.00606-07  0.399
2007 Husain M, Weisberg AS, Moss B. Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cells. Virology. 366: 424-32. PMID 17553539 DOI: 10.1016/J.Virol.2007.05.015  0.399
2007 Nigam P, Earl PL, Americo JL, Sharma S, Wyatt LS, Edghill-Spano Y, Chennareddi LS, Silvera P, Moss B, Robinson HL, Amara RR. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge. Virology. 366: 73-83. PMID 17507071 DOI: 10.1016/J.Virol.2007.04.010  0.404
2007 Earl PL, Americo JL, Wyatt LS, Eller LA, Montefiori DC, Byrum R, Piatak M, Lifson JD, Amara RR, Robinson HL, Huggins JW, Moss B. Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate. Virology. 366: 84-97. PMID 17499326 DOI: 10.1016/J.Virol.2007.02.041  0.474
2007 Parrish S, Resch W, Moss B. Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression. Proceedings of the National Academy of Sciences of the United States of America. 104: 2139-44. PMID 17283339 DOI: 10.1073/Pnas.0611685104  0.414
2007 Fogg CN, Americo JL, Lustig S, Huggins JW, Smith SK, Damon I, Resch W, Earl PL, Klinman DM, Moss B. Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges. Vaccine. 25: 2787-99. PMID 17229505 DOI: 10.1016/J.Vaccine.2006.12.037  0.728
2007 Charity JC, Katz E, Moss B. Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicin. Virology. 359: 227-32. PMID 17055024 DOI: 10.1016/J.Virol.2006.09.031  0.372
2007 Resch W, Hixson KK, Moore RJ, Lipton MS, Moss B. Protein composition of the vaccinia virus mature virion. Virology. 358: 233-47. PMID 17005230 DOI: 10.1016/J.Virol.2006.08.025  0.43
2007 Ojeda S, Senkevich TG, Moss B. Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene. Journal of Virology. 80: 51-61. PMID 16352530 DOI: 10.1128/Jvi.80.1.51-61.2006  0.524
2006 Liu J, Hellerstein M, McDonnel M, Amara RR, Wyatt LS, Moss B, Robinson HL. Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost. Vaccine. 25: 2951-8. PMID 17360078 DOI: 10.1016/J.Vaccine.2006.05.081  0.32
2006 de Waal L, Süzer Y, Wyatt LS, Sintnicolaas K, Sutter G, Moss B, Osterhaus AD, de Swart RL. T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells. Viral Immunology. 19: 669-78. PMID 17201662 DOI: 10.1089/Vim.2006.19.669  0.361
2006 Husain M, Weisberg AS, Moss B. Sequence-independent targeting of transmembrane proteins synthesized within vaccinia virus factories to nascent viral membranes. Journal of Virology. 81: 2646-55. PMID 17192302 DOI: 10.1128/Jvi.02631-06  0.482
2006 Husain M, Weisberg AS, Moss B. Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane. Proceedings of the National Academy of Sciences of the United States of America. 103: 19506-11. PMID 17146047 DOI: 10.1073/Pnas.0609406103  0.423
2006 Ojeda S, Domi A, Moss B. Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex. Journal of Virology. 80: 9822-30. PMID 16973586 DOI: 10.1128/Jvi.00987-06  0.526
2006 Brown E, Senkevich TG, Moss B. Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein. Journal of Virology. 80: 9455-64. PMID 16973551 DOI: 10.1128/Jvi.01149-06  0.443
2006 Townsley AC, Weisberg AS, Wagenaar TR, Moss B. Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. Journal of Virology. 80: 8899-908. PMID 16940502 DOI: 10.1128/Jvi.01053-06  0.419
2006 Robinson HL, Montefiori DC, Villinger F, Robinson JE, Sharma S, Wyatt LS, Earl PL, McClure HM, Moss B, Amara RR. Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine. Virology. 352: 285-94. PMID 16740288 DOI: 10.1016/J.Virol.2006.02.011  0.391
2006 Ellenberger D, Otten RA, Li B, Aidoo M, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Wyatt L, Hudgens MG, Kraiselburd E, Moss B, Robinson H, Folks T, Butera S. HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. Virology. 352: 216-25. PMID 16725169 DOI: 10.1016/J.Virol.2006.04.005  0.395
2006 Garcia AD, Otero J, Lebowitz J, Schuck P, Moss B. Quaternary structure and cleavage specificity of a poxvirus holliday junction resolvase. The Journal of Biological Chemistry. 281: 11618-26. PMID 16513635 DOI: 10.1074/Jbc.M600182200  0.413
2006 Liu J, Wyatt LS, Amara RR, Moss B, Robinson HL. Studies on in vitro expression and in vivo immunogenicity of a recombinant MVA HIV vaccine. Vaccine. 24: 3332-9. PMID 16472543 DOI: 10.1016/J.Vaccine.2006.01.017  0.346
2006 Chen Z, Earl P, Americo J, Damon I, Smith SK, Zhou YH, Yu F, Sebrell A, Emerson S, Cohen G, Eisenberg RJ, Svitel J, Schuck P, Satterfield W, Moss B, et al. Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. Proceedings of the National Academy of Sciences of the United States of America. 103: 1882-7. PMID 16436502 DOI: 10.1073/Pnas.0510598103  0.48
2006 Naik AM, Chalikonda S, McCart JA, Xu H, Guo ZS, Langham G, Gardner D, Mocellin S, Lokshin AE, Moss B, Alexander HR, Bartlett DL. Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates. Human Gene Therapy. 17: 31-45. PMID 16409123 DOI: 10.1089/Hum.2006.17.31  0.359
2006 Parrish S, Moss B. Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression. Journal of Virology. 80: 553-61. PMID 16378957 DOI: 10.1128/Jvi.80.2.553-561.2006  0.499
2006 Moss B. Poxvirus entry and membrane fusion. Virology. 344: 48-54. PMID 16364735 DOI: 10.1016/J.Virol.2005.09.037  0.417
2005 Senkevich TG, Ojeda S, Townsley A, Nelson GE, Moss B. Poxvirus multiprotein entry-fusion complex. Proceedings of the National Academy of Sciences of the United States of America. 102: 18572-7. PMID 16339313 DOI: 10.1073/pnas.0509239102  0.322
2005 Resch W, Moss B. The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes. Journal of Virology. 79: 14719-29. PMID 16282472 DOI: 10.1128/JVI.79.23.14719-14729.2005  0.44
2005 Guo ZS, Naik A, O'Malley ME, Popovic P, Demarco R, Hu Y, Yin X, Yang S, Zeh HJ, Moss B, Lotze MT, Bartlett DL. The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Research. 65: 9991-8. PMID 16267024 DOI: 10.1158/0008-5472.Can-05-1630  0.45
2005 Lustig S, Fogg C, Whitbeck JC, Eisenberg RJ, Cohen GH, Moss B. Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge. Journal of Virology. 79: 13454-62. PMID 16227266 DOI: 10.1128/Jvi.79.21.13454-13462.2005  0.696
2005 Szajner P, Weisberg AS, Lebowitz J, Heuser J, Moss B. External scaffold of spherical immature poxvirus particles is made of protein trimers, forming a honeycomb lattice. The Journal of Cell Biology. 170: 971-81. PMID 16144903 DOI: 10.1083/Jcb.200504026  0.401
2005 Townsley AC, Senkevich TG, Moss B. The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion. Journal of Virology. 79: 10988-98. PMID 16103150 DOI: 10.1128/Jvi.79.17.10988-10998.2005  0.52
2005 Aldaz-Carroll L, Whitbeck JC, Ponce de Leon M, Lou H, Pannell LK, Lebowitz J, Fogg C, White CL, Moss B, Cohen GH, Eisenberg RJ. Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene. Virology. 341: 59-71. PMID 16083934 DOI: 10.1016/J.Virol.2005.07.006  0.689
2005 Ellenberger D, Wyatt L, Li B, Buge S, Lanier N, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Vogt J, Smith J, Otten R, Montefiori D, Kraiselburd E, Moss B, et al. Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs. Virology. 340: 21-32. PMID 16023165 DOI: 10.1016/J.Virol.2005.06.014  0.372
2005 Townsley AC, Senkevich TG, Moss B. Vaccinia virus A21 virion membrane protein is required for cell entry and fusion. Journal of Virology. 79: 9458-69. PMID 16014909 DOI: 10.1128/Jvi.79.15.9458-9469.2005  0.512
2005 Chiu WL, Szajner P, Moss B, Chang W. Effects of a temperature sensitivity mutation in the J1R protein component of a complex required for vaccinia virus assembly. Journal of Virology. 79: 8046-56. PMID 15956550 DOI: 10.1128/Jvi.79.13.8046-8056.2005  0.485
2005 Resch W, Weisberg AS, Moss B. Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane. Journal of Virology. 79: 6598-609. PMID 15890898 DOI: 10.1128/JVI.79.11.6598-6609.2005  0.42
2005 Aldaz-Carroll L, Whitbeck JC, Ponce de Leon M, Lou H, Hirao L, Isaacs SN, Moss B, Eisenberg RJ, Cohen GH. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R. Journal of Virology. 79: 6260-71. PMID 15858010 DOI: 10.1128/Jvi.79.10.6260-6271.2005  0.483
2005 Senkevich TG, Moss B. Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion. Journal of Virology. 79: 4744-54. PMID 15795260 DOI: 10.1128/Jvi.79.8.4744-4754.2005  0.477
2005 De Silva FS, Moss B. Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors. Virology Journal. 2: 23. PMID 15784143 DOI: 10.1186/1743-422X-2-23  0.505
2005 Domi A, Moss B. Engineering of a vaccinia virus bacterial artificial chromosome in Escherichia coli by bacteriophage lambda-based recombination. Nature Methods. 2: 95-7. PMID 15782205 DOI: 10.1038/Nmeth734  0.403
2005 Bisht H, Roberts A, Vogel L, Subbarao K, Moss B. Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein. Virology. 334: 160-5. PMID 15780866 DOI: 10.1016/J.Virol.2005.01.042  0.422
2005 Husain M, Moss B. Role of receptor-mediated endocytosis in the formation of vaccinia virus extracellular enveloped particles Journal of Virology. 79: 4080-4089. PMID 15767409 DOI: 10.1128/Jvi.79.7.4080-4089.2005  0.508
2005 Su HP, Garman SC, Allison TJ, Fogg C, Moss B, Garboczi DN. The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies. Proceedings of the National Academy of Sciences of the United States of America. 102: 4240-5. PMID 15761054 DOI: 10.1073/Pnas.0501103102  0.656
2005 Sadagopal S, Amara RR, Montefiori DC, Wyatt LS, Staprans SI, Kozyr NL, McClure HM, Moss B, Robinson HL. Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2. Journal of Virology. 79: 3243-53. PMID 15731219 DOI: 10.1128/Jvi.79.6.3243-3253.2005  0.403
2005 Smith JM, Amara RR, Wyatt LS, Ellenberger DL, Li B, Herndon JG, Patel M, Sharma S, Chennareddi L, Butera S, McNicholl J, McClure HM, Moss B, Robinson HL. Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responses. Aids Research and Human Retroviruses. 21: 140-4. PMID 15725752 DOI: 10.1089/Aid.2005.21.140  0.349
2005 Greenier JL, Van Rompay KK, Montefiori D, Earl P, Moss B, Marthas ML. Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals. Virology Journal. 2: 11. PMID 15710048 DOI: 10.1186/1743-422X-2-11  0.416
2005 Van Rompay KK, Abel K, Lawson JR, Singh RP, Schmidt KA, Evans T, Earl P, Harvey D, Franchini G, Tartaglia J, Montefiori D, Hattangadi S, Moss B, Marthas ML. Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. Journal of Acquired Immune Deficiency Syndromes (1999). 38: 124-34. PMID 15671796 DOI: 10.1097/00126334-200502010-00002  0.379
2005 Szajner P, Jaffe H, Weisberg AS, Moss B. A complex of seven vaccinia virus proteins conserved in all chordopoxviruses is required for the association of membranes and viroplasm to form immature virions. Virology. 330: 447-59. PMID 15567438 DOI: 10.1016/J.Virol.2004.10.008  0.441
2005 Wyatt LS, Earl PL, Liu JY, Smith JM, Montefiori DC, Robinson HL, Moss B. Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component. Aids Research and Human Retroviruses. 20: 645-53. PMID 15242542 DOI: 10.1089/0889222041217428  0.404
2004 Smith JM, Amara RR, Campbell D, Xu Y, Patel M, Sharma S, Butera ST, Ellenberger DL, Yi H, Chennareddi L, Herndon JG, Wyatt LS, Montefiori D, Moss B, McClure HM, et al. DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime. Aids Research and Human Retroviruses. 20: 1335-47. PMID 15650426 DOI: 10.1089/Aid.2004.20.1335  0.389
2004 Katsafanas GC, Moss B. Vaccinia virus intermediate stage transcription is complemented by Ras-GTPase-activating protein SH3 domain-binding protein (G3BP) and cytoplasmic activation/proliferation-associated protein (p137) individually or as a heterodimer. The Journal of Biological Chemistry. 279: 52210-7. PMID 15471883 DOI: 10.1074/Jbc.M411033200  0.471
2004 Lustig S, Fogg C, Whitbeck JC, Moss B. Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement. Virology. 328: 30-5. PMID 15380355 DOI: 10.1016/J.Virol.2004.07.024  0.703
2004 da Fonseca FG, Weisberg AS, Caeiro MF, Moss B. Vaccinia virus mutants with alanine substitutions in the conserved G5R gene fail to initiate morphogenesis at the nonpermissive temperature. Journal of Virology. 78: 10238-48. PMID 15367589 DOI: 10.1128/JVI.78.19.10238-10248.2004  0.44
2004 Fogg C, Lustig S, Whitbeck JC, Eisenberg RJ, Cohen GH, Moss B. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. Journal of Virology. 78: 10230-7. PMID 15367588 DOI: 10.1128/Jvi.78.19.10230-10237.2004  0.727
2004 Puaux AL, Marsac D, Prost S, Singh MK, Earl P, Moss B, Le Grand R, Riviere Y, Michel ML. Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles. Vaccine. 22: 3535-45. PMID 15315833 DOI: 10.1016/J.Vaccine.2004.03.044  0.479
2004 Harrison SC, Alberts B, Ehrenfeld E, Enquist L, Fineberg H, McKnight SL, Moss B, O'Donnell M, Ploegh H, Schmid SL, Walter KP, Theriot J. Discovery of antivirals against smallpox. Proceedings of the National Academy of Sciences of the United States of America. 101: 11178-92. PMID 15249657 DOI: 10.1073/Pnas.0403600101  0.449
2004 Smith JM, Amara RR, McClure HM, Patel M, Sharma S, Yi H, Chennareddi L, Herndon JG, Butera ST, Heneine W, Ellenberger DL, Parekh B, Earl PL, Wyatt LS, Moss B, et al. Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques. Aids Research and Human Retroviruses. 20: 654-65. PMID 15242543 DOI: 10.1089/0889222041217419  0.387
2004 Ansarah-Sobrinho C, Moss B. Vaccinia virus G1 protein, a predicted metalloprotease, is essential for morphogenesis of infectious virions but not for cleavage of major core proteins. Journal of Virology. 78: 6855-63. PMID 15194761 DOI: 10.1128/JVI.78.13.6855-6863.2004  0.422
2004 Ansarah-Sobrinho C, Moss B. Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components. Journal of Virology. 78: 6335-43. PMID 15163727 DOI: 10.1128/Jvi.78.12.6335-6343.2004  0.45
2004 de Waal L, Wyatt LS, Yüksel S, van Amerongen G, Moss B, Niesters HG, Osterhaus AD, de Swart RL. Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology. Vaccine. 22: 923-6. PMID 15161069 DOI: 10.1016/J.Vaccine.2003.10.010  0.417
2004 Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proceedings of the National Academy of Sciences of the United States of America. 101: 6641-6. PMID 15096611 DOI: 10.1073/Pnas.0401939101  0.407
2004 Wyatt LS, Earl PL, Eller LA, Moss B. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge Proceedings of the National Academy of Sciences of the United States of America. 101: 4590-4595. PMID 15070762 DOI: 10.1073/Pnas.0401165101  0.459
2004 Ramsburg E, Rose NF, Marx PA, Mefford M, Nixon DF, Moretto WJ, Montefiori D, Earl P, Moss B, Rose JK. Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol. Journal of Virology. 78: 3930-40. PMID 15047809 DOI: 10.1128/Jvi.78.8.3930-3940.2004  0.516
2004 Earl PL, Americo JL, Wyatt LS, Eller LA, Whitbeck JC, Cohen GH, Eisenberg RJ, Hartmann CJ, Jackson DL, Kulesh DA, Martinez MJ, Miller DM, Mucker EM, Shamblin JD, Zwiers SH, ... ... Moss B, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature. 428: 182-5. PMID 15014500 DOI: 10.1038/Nature02331  0.341
2004 Ward BM, Moss B. Vaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesin. Journal of Virology. 78: 2486-93. PMID 14963148 DOI: 10.1128/Jvi.78.5.2486-2493.2004  0.647
2004 Senkevich TG, Ward BM, Moss B. Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene. Journal of Virology. 78: 2357-66. PMID 14963132 DOI: 10.1128/Jvi.78.5.2357-2366.2004  0.689
2004 Senkevich TG, Ward BM, Moss B. Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway. Journal of Virology. 78: 2348-56. PMID 14963131 DOI: 10.1128/Jvi.78.5.2348-2356.2004  0.722
2004 Center RJ, Lebowitz J, Leapman RD, Moss B. Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras. Journal of Virology. 78: 2265-76. PMID 14963123 DOI: 10.1128/Jvi.78.5.2265-2276.2004  0.397
2004 Szajner P, Weisberg AS, Moss B. Physical and functional interactions between vaccinia virus F10 protein kinase and virion assembly proteins A30 and G7. Journal of Virology. 78: 266-74. PMID 14671108 DOI: 10.1128/Jvi.78.1.266-274.2004  0.312
2004 Szajner P, Weisberg AS, Moss B. Evidence for an essential catalytic role of the F10 protein kinase in vaccinia virus morphogenesis. Journal of Virology. 78: 257-65. PMID 14671107 DOI: 10.1128/Jvi.78.1.257-265.2004  0.416
2004 Guo Z, Naik A, Hu Y, DeMarco R, O'Malley M, Alexander R, Moss B, Lotze M, Bartlett DL. 65. Systemic Cancer Therapy with an Enhanced Tumor-Selective Vaccinia Virus Lacking Anti-Apoptosis Viral Genes Spi-2 and Spi-1 Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.05.083  0.461
2003 Buge SL, Ma HL, Amara RR, Wyatt LS, Earl PL, Villinger F, Montefiori DC, Staprans SI, Xu Y, Carter E, O'Neil SP, Herndon JG, Hill E, Moss B, Robinson HL, et al. Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge. Aids Research and Human Retroviruses. 19: 891-900. PMID 14585221 DOI: 10.1089/088922203322493067  0.404
2003 Katz E, Ward BM, Weisberg AS, Moss B. Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein. Journal of Virology. 77: 12266-75. PMID 14581563 DOI: 10.1128/Jvi.77.22.12266-12275.2003  0.696
2003 Husain M, Moss B. Evidence against an Essential Role of COPII-Mediated Cargo Transport to the Endoplasmic Reticulum-Golgi Intermediate Compartment in the Formation of the Primary Membrane of Vaccinia Virus Journal of Virology. 77: 11754-11766. PMID 14557660 DOI: 10.1128/Jvi.77.21.11754-11766.2003  0.421
2003 Edghill-Smith Y, Venzon D, Karpova T, McNally J, Nacsa J, Tsai WP, Tryniszewska E, Moniuszko M, Manischewitz J, King LR, Snodgrass SJ, Parrish J, Markham P, Sowers M, Martin D, ... ... Moss B, et al. Modeling a Safer Smallpox Vaccination Regimen, for Human Immunodeficiency Virus Type 1-Infected Patients, in Immunocompromised Macaques Journal of Infectious Diseases. 188: 1181-1191. PMID 14551889 DOI: 10.1086/378518  0.436
2003 Chan FK, Shisler J, Bixby JG, Felices M, Zheng L, Appel M, Orenstein J, Moss B, Lenardo MJ. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. The Journal of Biological Chemistry. 278: 51613-21. PMID 14532286 DOI: 10.1074/Jbc.M305633200  0.322
2003 Da Fonseca F, Moss B. Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription. Proceedings of the National Academy of Sciences of the United States of America. 100: 11291-6. PMID 12972642 DOI: 10.1073/Pnas.1534874100  0.497
2003 Husain M, Moss B. Intracellular trafficking of a palmitoylated membrane-associated protein component of enveloped vaccinia virus Journal of Virology. 77: 9008-9019. PMID 12885917 DOI: 10.1128/Jvi.77.16.9008-9019.2003  0.402
2003 Belyakov IM, Earl P, Dzutsev A, Kuznetsov VA, Lemon M, Wyatt LS, Snyder JT, Ahlers JD, Franchini G, Moss B, Berzofsky JA. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proceedings of the National Academy of Sciences of the United States of America. 100: 9458-63. PMID 12869693 DOI: 10.1073/Pnas.1233578100  0.429
2003 Husain M, Weisberg A, Moss B. Topology of epitope-tagged F13L protein, a major membrane component of extracellular vaccinia virions. Virology. 308: 233-42. PMID 12706074 DOI: 10.1016/S0042-6822(03)00063-1  0.402
2003 Ward BM, Weisberg AS, Moss B. Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. Journal of Virology. 77: 4113-26. PMID 12634370 DOI: 10.1128/Jvi.77.7.4113-4126.2003  0.661
2003 Szajner P, Jaffe H, Weisberg AS, Moss B. Vaccinia virus G7L protein Interacts with the A30L protein and is required for association of viral membranes with dense viroplasm to form immature virions. Journal of Virology. 77: 3418-29. PMID 12610117 DOI: 10.1128/Jvi.77.6.3418-3429.2003  0.496
2003 Xiang Y, Moss B. Molluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furin-cleaved form with only the IL-18 binding domain. Journal of Virology. 77: 2623-30. PMID 12552001 DOI: 10.1128/Jvi.77.4.2623-2630.2003  0.305
2003 Ishii K, Moss B. Mapping interaction sites of the A20R protein component of the vaccinia virus DNA replication complex. Virology. 303: 232-9. PMID 12490386 DOI: 10.1006/Viro.2002.1721  0.444
2003 Yang ZY, Wyatt LS, Kong WP, Moodie Z, Moss B, Nabel GJ. Overcoming immunity to a viral vaccine by DNA priming before vector boosting. Journal of Virology. 77: 799-803. PMID 12477888 DOI: 10.1128/Jvi.77.1.799-803.2003  0.461
2003 Van Rompay KK, Greenier JL, Cole KS, Earl P, Moss B, Steckbeck JD, Pahar B, Rourke T, Montelaro RC, Canfield DR, Tarara RP, Miller C, McChesney MB, Marthas ML. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. Journal of Virology. 77: 179-90. PMID 12477823 DOI: 10.1128/Jvi.77.1.179-190.2003  0.417
2003 De Silva FS, Moss B. Vaccinia virus uracil DNA glycosylase has an essential role in DNA synthesis that is independent of its glycosylase activity: catalytic site mutations reduce virulence but not virus replication in cultured cells. Journal of Virology. 77: 159-66. PMID 12477821 DOI: 10.1128/Jvi.77.1.159-166.2003  0.427
2003 Earl PL, Americo JL, Moss B. Development and Use of a Vaccinia Virus Neutralization Assay Based on Flow Cytometric Detection of Green Fluorescent Protein Journal of Virology. 77: 12930-12930. DOI: 10.1128/Jvi.77.19.10684-10688.2003  0.415
2002 Katz E, Wolffe E, Moss B. Identification of second-site mutations that enhance release and spread of vaccinia virus. Journal of Virology. 76: 11637-44. PMID 12388724 DOI: 10.1128/Jvi.76.22.11637-11644.2002  0.498
2002 Baig J, Levy DB, McKay PF, Schmitz JE, Santra S, Subbramanian RA, Kuroda MJ, Lifton MA, Gorgone DA, Wyatt LS, Moss B, Huang Y, Chakrabarti BK, Xu L, Kong WP, et al. Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination. Journal of Virology. 76: 11484-90. PMID 12388710 DOI: 10.1128/Jvi.76.22.11484-11490.2002  0.434
2002 Senkevich TG, White CL, Weisberg A, Granek JA, Wolffe EJ, Koonin EV, Moss B. Expression of the vaccinia virus A2.5L redox protein is required for virion morphogenesis. Virology. 300: 296-303. PMID 12350360 DOI: 10.1006/Viro.2002.1608  0.447
2002 Domi A, Moss B. Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 12415-20. PMID 12196634 DOI: 10.1073/Pnas.192420599  0.452
2002 Shchelkunov SN, Totmenin AV, Safronov PF, Gutorov VV, Ryazankina OI, Petrov NA, Babkin IV, Uvarova EA, Mikheev MV, Sisler JR, Esposito JJ, Jahrling PB, Moss B, Sandakhchiev LS. Multiple genetic differences between the monkeypox and variola viruses. Doklady Biochemistry and Biophysics. 384: 143-147. PMID 12134509 DOI: 10.1023/A:1016016013042  0.302
2002 Center RJ, Leapman RD, Lebowitz J, Arthur LO, Earl PL, Moss B. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. Journal of Virology. 76: 7863-7. PMID 12097599 DOI: 10.1128/Jvi.76.15.7863-7867.2002  0.475
2002 Husain M, Moss B. Similarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D Journal of Virology. 76: 7777-7789. PMID 12097590 DOI: 10.1128/Jvi.76.15.7777-7789.2002  0.508
2002 Amara RR, Villinger F, Staprans SI, Altman JD, Montefiori DC, Kozyr NL, Xu Y, Wyatt LS, Earl PL, Herndon JG, McClure HM, Moss B, Robinson HL. Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines. Journal of Virology. 76: 7625-31. PMID 12097576 DOI: 10.1128/Jvi.76.15.7625-7631.2002  0.381
2002 Shchelkunov SN, Totmenin AV, Safronov PF, Mikheev MV, Gutorov VV, Ryazankina OI, Petrov NA, Babkin IV, Uvarova EA, Sandakhchiev LS, Sisler JR, Esposito JJ, Damon IK, Jahrling PB, Moss B. Analysis of the monkeypox virus genome. Virology. 297: 172-94. PMID 12083817 DOI: 10.1006/Viro.2002.1446  0.41
2002 Santra S, Barouch DH, Kuroda MJ, Schmitz JE, Krivulka GR, Beaudry K, Lord CI, Lifton MA, Wyatt LS, Moss B, Hirsch VM, Letvin NL. Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infection. Journal of Virology. 76: 6376-81. PMID 12021371 DOI: 10.1128/Jvi.76.12.6376-6381.2002  0.49
2002 Amara RR, Smith JM, Staprans SI, Montefiori DC, Villinger F, Altman JD, O'Neil SP, Kozyr NL, Xu Y, Wyatt LS, Earl PL, Herndon JG, McNicholl JM, McClure HM, Moss B, et al. Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine. Journal of Virology. 76: 6138-46. PMID 12021347 DOI: 10.1128/Jvi.76.12.6138-6146.2002  0.473
2002 Earl PL, Wyatt LS, Montefiori DC, Bilska M, Woodward R, Markham PD, Malley JD, Vogel TU, Allen TM, Watkins DI, Miller N, Moss B. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric env protein boost in the SHIV rhesus macaque model Virology. 294: 270-281. PMID 12009868 DOI: 10.1006/Viro.2001.1345  0.445
2002 Senkevich TG, White CL, Koonin EV, Moss B. Complete pathway for protein disulfide bond formation encoded by poxviruses. Proceedings of the National Academy of Sciences of the United States of America. 99: 6667-72. PMID 11983854 DOI: 10.1073/Pnas.062163799  0.37
2002 Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, ... ... Moss B, et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Vaccine. 20: 1949-55. PMID 11983252 DOI: 10.1016/S0264-410X(02)00076-2  0.401
2002 White CL, Senkevich TG, Moss B. Vaccinia virus G4L glutaredoxin is an essential intermediate of a cytoplasmic disulfide bond pathway required for virion assembly Journal of Virology. 76: 467-472. PMID 11752136 DOI: 10.1128/Jvi.76.2.467-472.2002  0.424
2002 Shchelkunov SN, Totmenin AV, Babkin IV, Safronov PF, Ryazankina OI, Petrov NA, Gutorov VV, Uvarova EA, Mikheev MV, Sisler JR, Esposito JJ, Jahrling PB, Moss B, Sandakhchiev LS. Human monkeypox and smallpox viruses: genomic comparison. Febs Letters. 509: 66-70. PMID 11734207 DOI: 10.1016/S0014-5793(01)03144-1  0.381
2001 Earl PL, Moss B, Wyatt LS, Carroll MW. UNIT 16.17 Generation of Recombinant Vaccinia Viruses Current Protocols in Protein Science. PMID 18265124 DOI: 10.1002/0471142727.Mb1617S43  0.499
2001 Center RJ, Schuck P, Leapman RD, Arthur LO, Earl PL, Moss B, Lebowitz J. Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation. Proceedings of the National Academy of Sciences of the United States of America. 98: 14877-82. PMID 11752436 DOI: 10.1073/Pnas.261573898  0.455
2001 Moss B, Ward BM. High-speed mass transit for poxviruses on microtubules. Nature Cell Biology. 3: E245-6. PMID 11715030 DOI: 10.1038/Ncb1101-E245  0.568
2001 Ward BM, Moss B. Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. Journal of Virology. 75: 11651-63. PMID 11689647 DOI: 10.1128/Jvi.75.23.11651-11663.2001  0.686
2001 Hu Y, Lee J, McCart JA, Xu H, Moss B, Alexander HR, Bartlett DL. Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy. Journal of Virology. 75: 10300-8. PMID 11581398 DOI: 10.1128/Jvi.75.21.10300-10308.2001  0.504
2001 Xiang Y, Moss B. Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins Journal of Virology. 75: 9947-9954. PMID 11559827 DOI: 10.1128/Jvi.75.20.9947-9954.2001  0.328
2001 Husain M, Moss B. Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles Journal of Virology. 75: 7528-7542. PMID 11462025 DOI: 10.1128/Jvi.75.16.7528-7542.2001  0.491
2001 Garcia AD, Moss B. Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes Journal of Virology. 75: 6460-6471. PMID 11413313 DOI: 10.1128/Jvi.75.14.6460-6471.2001  0.515
2001 Stittelaar KJ, Kuiken T, de Swart RL, van Amerongen G, Vos HW, Niesters HG, van Schalkwijk P, van der Kwast T, Wyatt LS, Moss B, Osterhaus AD. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine. 19: 3700-9. PMID 11395204 DOI: 10.1016/S0264-410X(01)00075-5  0.479
2001 Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, ... ... Moss B, et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (New York, N.Y.). 292: 69-74. PMID 11393868 DOI: 10.1126/Science.1058915  0.399
2001 Szajner P, Weisberg AS, Wolffe EJ, Moss B. Vaccinia virus A30L protein is required for association of viral membranes with dense viroplasm to form immature virions. Journal of Virology. 75: 5752-61. PMID 11390577 DOI: 10.1128/JVI.75.13.5752-5761.2001  0.37
2001 Barouch DH, Santra S, Kuroda MJ, Schmitz JE, Plishka R, Buckler-White A, Gaitan AE, Zin R, Nam JH, Wyatt LS, Lifton MA, Nickerson CE, Moss B, Montefiori DC, Hirsch VM, et al. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination. Journal of Virology. 75: 5151-8. PMID 11333896 DOI: 10.1128/Jvi.75.11.5151-5158.2001  0.462
2001 Ward BM, Moss B. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. Journal of Virology. 75: 4802-13. PMID 11312352 DOI: 10.1128/Jvi.75.10.4802-4813.2001  0.667
2001 Shisler JL, Moss B. Immunology 102 at poxvirus U: avoiding apoptosis. Seminars in Immunology. 13: 67-72. PMID 11289801 DOI: 10.1006/Smim.2000.0297  0.376
2001 Moss B, Shisler JL. Immunology 101 at poxvirus U: immune evasion genes. Seminars in Immunology. 13: 59-66. PMID 11289800 DOI: 10.1006/Smim.2000.0296  0.43
2001 Kovacs GR, Vasilakis N, Moss B. Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase Journal of Virology. 75: 4048-4055. PMID 11287554 DOI: 10.1128/Jvi.75.9.4048-4055.2001  0.44
2001 Shisler JL, Moss B. Molluscum contagiosum virus inhibitors of apoptosis: The MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology. 282: 14-25. PMID 11259186 DOI: 10.1006/Viro.2001.0834  0.446
2001 Barouch DH, Craiu A, Santra S, Egan MA, Schmitz JE, Kuroda MJ, Fu TM, Nam JH, Wyatt LS, Lifton MA, Krivulka GR, Nickerson CE, Lord CI, Moss B, Lewis MG, et al. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys. Journal of Virology. 75: 2462-7. PMID 11160750 DOI: 10.1128/Jvi.75.5.2462-2467.2001  0.461
2001 Ishii K, Moss B. Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants. Journal of Virology. 75: 1656-63. PMID 11160663 DOI: 10.1128/Jvi.75.4.1656-1663.2001  0.468
2001 Earl PL, Sugiura W, Montefiori DC, Broder CC, Lee SA, Wild C, Lifson J, Moss B. Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. Journal of Virology. 75: 645-53. PMID 11134278 DOI: 10.1128/Jvi.75.2.645-653.2001  0.456
2001 Wolffe EJ, Weisberg AS, Moss B. The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. Journal of Virology. 75: 303-10. PMID 11119600 DOI: 10.1128/Jvi.75.1.303-310.2001  0.42
2001 Senkevich TG, Weisberg AS, Moss B. Vaccinia virus E10R protein is associated with the membranes of intracellular mature virions and has a role in morphogenesis. Virology. 278: 244-52. PMID 11112499 DOI: 10.1006/Viro.2000.0656  0.515
2000 Moss B, Shisler JL, Xiang Y, Senkevich TG. Immune-defense molecules of molluscum contagiosum virus, a human poxvirus. Trends in Microbiology. 8: 473-7. PMID 11044683 DOI: 10.1016/S0966-842X(00)01838-2  0.467
2000 Senkevich TG, White CL, Koonin EV, Moss B. A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation. Proceedings of the National Academy of Sciences of the United States of America. 97: 12068-73. PMID 11035794 DOI: 10.1073/Pnas.210397997  0.471
2000 Zhu Yd, Rota P, Wyatt L, Tamin A, Rozenblatt S, Lerche N, Moss B, Bellini W, McChesney M. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody. Virology. 276: 202-13. PMID 11022008 DOI: 10.1006/Viro.2000.0564  0.405
2000 Yeh WW, Moss B, Wolffe EJ. The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis. Journal of Virology. 74: 9701-11. PMID 11000242 DOI: 10.1128/Jvi.74.20.9701-9711.2000  0.507
2000 White CL, Weisberg AS, Moss B. A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis Journal of Virology. 74: 9175-9183. PMID 10982364 DOI: 10.1128/Jvi.74.19.9175-9183.2000  0.564
2000 da Fonseca FG, Wolffe EJ, Weisberg A, Moss B. Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication. Journal of Virology. 74: 7518-28. PMID 10906205 DOI: 10.1128/Jvi.74.16.7518-7528.2000  0.555
2000 da Fonseca FG, Wolffe EJ, Weisberg A, Moss B. Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail. Journal of Virology. 74: 7508-17. PMID 10906204 DOI: 10.1128/Jvi.74.16.7508-7517.2000  0.461
2000 Garcia AD, Aravind L, Koonin EV, Moss B. Bacterial-type DNA Holliday junction resolvases in eukaryotic viruses Proceedings of the National Academy of Sciences of the United States of America. 97: 8926-8931. PMID 10890916 DOI: 10.1073/Pnas.150238697  0.431
2000 Men R, Wyatt L, Tokimatsu I, Arakaki S, Shameem G, Elkins R, Chanock R, Moss B, Lai CJ. Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge. Vaccine. 18: 3113-22. PMID 10856791 DOI: 10.1016/S0264-410X(00)00121-3  0.492
2000 McCraith S, Holtzman T, Moss B, Fields S. Genome-wide analysis of vaccinia virus protein-protein interactions. Proceedings of the National Academy of Sciences of the United States of America. 97: 4879-84. PMID 10781095 DOI: 10.1073/Pnas.080078197  0.426
2000 Allen TM, Vogel TU, Fuller DH, Mothé BR, Steffen S, Boyson JE, Shipley T, Fuller J, Hanke T, Sette A, Altman JD, Moss B, McMichael AJ, Watkins DI. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. Journal of Immunology (Baltimore, Md. : 1950). 164: 4968-78. PMID 10779808 DOI: 10.4049/Jimmunol.164.9.4968  0.41
2000 Center RJ, Earl PL, Lebowitz J, Schuck P, Moss B. The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts. Journal of Virology. 74: 4448-55. PMID 10775580 DOI: 10.1128/Jvi.74.10.4448-4455.2000  0.411
2000 Stittelaar KJ, Wyatt LS, de Swart RL, Vos HW, Groen J, van Amerongen G, van Binnendijk RS, Rozenblatt S, Moss B, Osterhaus AD. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. Journal of Virology. 74: 4236-43. PMID 10756037 DOI: 10.1128/Jvi.74.9.4236-4243.2000  0.389
2000 Betakova T, Wolffe EJ, Moss B. The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses. Journal of Virology. 74: 4085-92. PMID 10756020 DOI: 10.1128/Jvi.74.9.4085-4092.2000  0.508
2000 Ward BM, Moss B. Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein. Journal of Virology. 74: 3771-80. PMID 10729152 DOI: 10.1128/Jvi.74.8.3771-3780.2000  0.646
2000 Ourmanov I, Brown CR, Moss B, Carroll M, Wyatt L, Pletneva L, Goldstein S, Venzon D, Hirsch VM. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV. Journal of Virology. 74: 2740-51. PMID 10684290 DOI: 10.1128/Jvi.74.6.2740-2751.2000  0.475
2000 Seth A, Ourmanov I, Schmitz JE, Kuroda MJ, Lifton MA, Nickerson CE, Wyatt L, Carroll M, Moss B, Venzon D, Letvin NL, Hirsch VM. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge Journal of Virology. 74: 2502-2509. PMID 10684264 DOI: 10.1128/Jvi.74.6.2502-2509.2000  0.469
2000 Betakova T, Moss B. Disulfide bonds and membrane topology of the vaccinia virus A17L envelope protein. Journal of Virology. 74: 2438-42. PMID 10666276 DOI: 10.1128/Jvi.74.5.2438-2442.2000  0.409
1999 Crawford JM, Earl PL, Moss B, Reimann KA, Wyand MS, Manson KH, Bilska M, Zhou JT, Pauza CD, Parren PWHI, Burton DR, Sodroski JG, Letvin NL, Montefiori DC. Characterization of primary isolate-like variants of simian-human immunodeficiency virus Journal of Virology. 73: 10199-10207. PMID 10559336 DOI: 10.1128/Jvi.73.12.10199-10207.1999  0.433
1999 Wyatt LS, Whitehead SS, Venanzi KA, Murphy BR, Moss B. Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA. Vaccine. 18: 392-7. PMID 10519927 DOI: 10.1016/S0264-410X(99)00257-1  0.49
1999 Shisler JL, Isaacs SN, Moss B. Vaccinia virus serpin-1 deletion mutant exhibits a host range defect characterized by low levels of intermediate and late mRNAs. Virology. 262: 298-311. PMID 10502509 DOI: 10.1006/Viro.1999.9884  0.489
1999 Xiang Y, Moss B. IL-18 binding and inhibition of interferon γ induction-by human poxvirus-encoded proteins Proceedings of the National Academy of Sciences of the United States of America. 96: 11537-11542. PMID 10500212 DOI: 10.1073/Pnas.96.20.11537  0.345
1999 Betakova T, Wolffe EJ, Moss B. Membrane topology of the vaccinia virus A17L envelope protein. Virology. 261: 347-56. PMID 10497120 DOI: 10.1006/Viro.1999.9870  0.351
1999 Katsafanas GC, Moss B. Histidine codons appended to the gene encoding the RPO22 subunit of vaccinia virus RNA polymerase facilitate the isolation and purification of functional enzyme and associated proteins from virus-infected cells. Virology. 258: 469-79. PMID 10366585 DOI: 10.1006/Viro.1999.9744  0.432
1999 Xiang Y, Moss B. Identification of human and mouse homologs of the MC51L-53L-54L family of secreted glycoproteins encoded by the Molluscum contagiosum poxvirus. Virology. 257: 297-302. PMID 10329540 DOI: 10.1006/Viro.1999.9676  0.405
1999 Durbin AP, Cho CJ, Elkins WR, Wyatt LS, Moss B, Murphy BR. Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfiuenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies Journal of Infectious Diseases. 179: 1345-1351. PMID 10228053 DOI: 10.1086/314769  0.5
1999 Belyakov IM, Moss B, Strober W, Berzofsky JA. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proceedings of the National Academy of Sciences of the United States of America. 96: 4512-7. PMID 10200293 DOI: 10.1073/Pnas.96.8.4512  0.333
1999 Overwijk WW, Lee DS, Surman DR, Irvine KR, Touloukian CE, Chan CC, Carroll MW, Moss B, Rosenberg SA, Restifo NP. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 96: 2982-7. PMID 10077623 DOI: 10.1073/Pnas.96.6.2982  0.384
1999 Sanz P, Moss B. Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression. Proceedings of the National Academy of Sciences of the United States of America. 96: 2692-7. PMID 10077573 DOI: 10.1073/Pnas.96.6.2692  0.508
1999 Nam JH, Wyatt LS, Chae SL, Cho HW, Park YK, Moss B. Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes. Vaccine. 17: 261-8. PMID 9987162 DOI: 10.1016/S0264-410X(98)00156-X  0.515
1999 Sugiura W, Broder CC, Moss B, Earl PL. Characterization of conformation-dependent anti-gp120 murine monoclonal antibodies produced by immunization with monomeric and oligomeric human immunodeficiency virus type 1 envelope proteins. Virology. 254: 257-67. PMID 9986792 DOI: 10.1006/Viro.1998.9549  0.407
1999 Belyakov IM, Ahlers JD, Brandwein BY, Earl P, Kelsall BL, Moss B, Strober W, Berzofsky JA. The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. The Journal of Clinical Investigation. 102: 2072-81. PMID 9854042 DOI: 10.1172/Jci5102  0.402
1999 Betakova T, Wolffe EJ, Moss B. Regulation of Vaccinia Virus Morphogenesis: Phosphorylation of the A14L and A17L Membrane Proteins and C-Terminal Truncation of the A17L Protein Are Dependent on the F10L Kinase Journal of Virology. 73: 3534-3543. DOI: 10.1128/Jvi.73.5.3534-3543.1999  0.336
1999 Roper RL, Moss B. Envelope Formation Is Blocked by Mutation of a Sequence Related to the HKD Phospholipid Metabolism Motif in the Vaccinia Virus F13L Protein Journal of Virology. 73: 1108-1117. DOI: 10.1128/Jvi.73.2.1108-1117.1999  0.507
1999 Crawford JM, Earl PL, Moss B, Reimann KA, Wyand MS, Manson KH, Bilska M, Zhou JT, Pauza CD, Parren PWHI, Burton DR, Sodroski JG, Letvin NL, Montefiori DC. Characterization of Primary Isolate-Like Variants of Simian-Human Immunodeficiency Virus Journal of Virology. 73: 10199-10207. DOI: 10.1128/jvi.73.12.10199-10207.1999  0.32
1999 Shors T, Keck JG, Moss B. Down Regulation of Gene Expression by the Vaccinia Virus D10 Protein Journal of Virology. 73: 791-796. DOI: 10.1128/Jvi.73.1.791-796.1999  0.492
1998 Carroll MW, Overwijk WW, Surman DR, Tsung K, Moss B, Restifo NP. Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen. Journal of the National Cancer Institute. 90: 1881-7. PMID 9862625 DOI: 10.1093/Jnci/90.24.1881  0.401
1998 Wyatt LS, Carroll MW, Czerny CP, Merchlinsky M, Sisler JR, Moss B. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara Virology. 251: 334-342. PMID 9837798 DOI: 10.1006/Viro.1998.9397  0.505
1998 Senkevich TG, Moss B. Domain structure, intracellular trafficking, and beta2-microglobulin binding of a major histocompatibility complex class I homolog encoded by molluscum contagiosum virus. Virology. 250: 397-407. PMID 9792850 DOI: 10.1006/Viro.1998.9390  0.381
1998 Seth A, Ourmanov I, Kuroda MJ, Schmitz JE, Carroll MW, Wyatt LS, Moss B, Forman MA, Hirsch VM, Letvin NL. Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer Proceedings of the National Academy of Sciences of the United States of America. 95: 10112-10116. PMID 9707609 DOI: 10.1073/Pnas.95.17.10112  0.44
1998 Durbin AP, Wyatt LS, Siew J, Moss B, Murphy BR. The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys. Vaccine. 16: 1324-30. PMID 9682397 DOI: 10.1016/S0264-410X(98)00010-3  0.422
1998 Overwijk WW, Tsung A, Irvine KR, Parkhurst MR, Goletz TJ, Tsung K, Carroll MW, Liu C, Moss B, Rosenberg SA, Restifo NP. gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. The Journal of Experimental Medicine. 188: 277-86. PMID 9670040 DOI: 10.1084/Jem.188.2.277  0.364
1998 Damon I, Murphy PM, Moss B. Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proceedings of the National Academy of Sciences of the United States of America. 95: 6403-7. PMID 9600978 DOI: 10.1073/Pnas.95.11.6403  0.386
1998 Wolffe EJ, Weisberg AS, Moss B. Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread. Virology. 244: 20-6. PMID 9581774 DOI: 10.1006/Viro.1998.9103  0.5
1998 Bugert JJ, Lohmüller C, Damon I, Moss B, Darai G. Chemokine homolog of molluscum contagiosum virus: sequence conservation and expression. Virology. 242: 51-9. PMID 9501046 DOI: 10.1006/Viro.1997.9001  0.433
1998 Ramsey-Ewing A, Moss B. Apoptosis induced by a postbinding step of vaccinia virus entry into Chinese hamster ovary cells. Virology. 242: 138-49. PMID 9501038 DOI: 10.1006/Viro.1997.8985  0.466
1998 Belyakov IM, Derby MA, Ahlers JD, Kelsall BL, Earl P, Moss B, Strober W, Berzofsky JA. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proceedings of the National Academy of Sciences of the United States of America. 95: 1709-14. PMID 9465081 DOI: 10.1073/Pnas.95.4.1709  0.378
1998 Chakrabarti S, Sisler JR, Moss B. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques. 23: 1094-7. PMID 9421642 DOI: 10.2144/97236St07  0.497
1998 Shisler JL, Senkevich TG, Berry MJ, Moss B. Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. Science (New York, N.Y.). 279: 102-5. PMID 9417017 DOI: 10.1126/Science.279.5347.102  0.369
1998 Carroll MW, Moss B. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology. 238: 198-211. PMID 9400593 DOI: 10.1006/Viro.1997.8845  0.366
1998 Katz E, Moss B. Immunogenicity of recombinant vaccinia viruses that display the HIV type 1 envelope glycoprotein on the surface of infectious virions. Aids Research and Human Retroviruses. 13: 1497-500. PMID 9390748 DOI: 10.1089/Aid.1997.13.1497  0.48
1998 Sanz P, Moss B. A New Vaccinia Virus Intermediate Transcription Factor Journal of Virology. 72: 6880-6883. DOI: 10.1128/Jvi.72.8.6880-6883.1998  0.503
1998 Cassetti MC, Merchlinsky M, Wolffe EJ, Weisberg AS, Moss B. DNA Packaging Mutant: Repression of the Vaccinia Virus A32 Gene Results in Noninfectious, DNA-Deficient, Spherical, Enveloped Particles Journal of Virology. 72: 5769-5780. DOI: 10.1128/Jvi.72.7.5769-5780.1998  0.494
1998 Roper RL, Wolffe EJ, Weisberg A, Moss B. The Envelope Protein Encoded by the A33R Gene Is Required for Formation of Actin-Containing Microvilli and Efficient Cell-to-Cell Spread of Vaccinia Virus Journal of Virology. 72: 4192-4204. DOI: 10.1128/Jvi.72.5.4192-4204.1998  0.534
1998 Belyakov IM, Wyatt LS, Ahlers JD, Earl P, Pendleton CD, Kelsall BL, Strober W, Moss B, Berzofsky JA. Induction of a Mucosal Cytotoxic T-Lymphocyte Response by Intrarectal Immunization with a Replication-Deficient Recombinant Vaccinia Virus Expressing Human Immunodeficiency Virus 89.6 Envelope Protein Journal of Virology. 72: 8264-8272. DOI: 10.1128/Jvi.72.10.8264-8272.1998  0.494
1998 Hu X, Wolffe EJ, Weisberg AS, Carroll LJ, Moss B. Repression of the A8L Gene, Encoding the Early Transcription Factor 82-Kilodalton Subunit, Inhibits Morphogenesis of Vaccinia Virions Journal of Virology. 72: 104-112. DOI: 10.1128/Jvi.72.1.104-112.1998  0.494
1997 Carroll MW, Moss B. Poxviruses as expression vectors. Current Opinion in Biotechnology. 8: 573-7. PMID 9353230 DOI: 10.1016/S0958-1669(97)80031-6  0.437
1997 Sung TC, Roper RL, Zhang Y, Rudge SA, Temel R, Hammond SM, Morris AJ, Moss B, Engebrecht J, Frohman MA. Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity Embo Journal. 16: 4519-4530. PMID 9303296 DOI: 10.1093/emboj/16.15.4519  0.396
1997 Yang S, Carroll MW, Torres-Duarte AP, Moss B, Davidson EA. Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus. Vaccine. 15: 1303-13. PMID 9302735 DOI: 10.1016/S0264-410X(97)00039-X  0.421
1997 Katsafanas GC, Grem JL, Blough HA, Moss B. Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool. Virology. 236: 177-87. PMID 9299630 DOI: 10.1006/Viro.1997.8735  0.485
1997 Senkevich TG, Koonin EV, Bugert JJ, Darai G, Moss B. The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology. 233: 19-42. PMID 9201214 DOI: 10.1006/Viro.1997.8607  0.421
1997 Carroll MW, Overwijk WW, Chamberlain RS, Rosenberg SA, Moss B, Restifo NP. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model. Vaccine. 15: 387-94. PMID 9141209 DOI: 10.1016/S0264-410X(96)00195-8  0.384
1997 Bronte V, Carroll MW, Goletz TJ, Wang M, Overwijk WW, Marincola F, Rosenberg SA, Moss B, Restifo NP. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proceedings of the National Academy of Sciences of the United States of America. 94: 3183-8. PMID 9096367 DOI: 10.1073/Pnas.94.7.3183  0.348
1997 Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, Banks S, Wang GH, Senkevich TG, Alnemri ES, Moss B, Lenardo MJ, Tomaselli KJ, Cohen JI. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 94: 1172-6. PMID 9037025 DOI: 10.1073/Pnas.94.4.1172  0.374
1997 Gershon P, Moss B. Expression, purification, and characterization of vaccinia virus-encoded RNA and poly(A) polymerases. Methods in Enzymology. 275: 208-27. PMID 9026640 DOI: 10.1016/S0076-6879(96)75014-0  0.432
1997 Wyatt LS, Shors ST, Murphy BR, Moss B. Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model. Vaccine. 14: 1451-8. PMID 8994321 DOI: 10.1016/S0264-410X(96)00072-2  0.52
1997 Moss B, Carroll MW, Wyatt LS, Bennink JR, Hirsch VM, Goldstein S, Elkins WR, Fuerst TR, Lifson JD, Piatak M, Restifo NP, Overwijk W, Chamberlain R, Rosenberg SA, Sutter G. Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates. Advances in Experimental Medicine and Biology. 397: 7-13. PMID 8718576 DOI: 10.1007/978-1-4899-1382-1_2  0.411
1997 Wolffe EJ, Katz E, Weisberg A, Moss B. The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. Journal of Virology. 71: 3904-3915. DOI: 10.1128/jvi.71.5.3904-3915.1997  0.329
1997 Katz E, Wolffe EJ, Moss B. The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions. Journal of Virology. 71: 3178-3187. DOI: 10.1128/jvi.71.4.3178-3187.1997  0.407
1997 Earl PL, Broder CC, Doms RW, Moss B. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein. Journal of Virology. 71: 2674-2684. DOI: 10.1128/jvi.71.4.2674-2684.1997  0.318
1996 Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety Proceedings of the National Academy of Sciences of the United States of America. 93: 11341-11348. PMID 8876137 DOI: 10.1073/Pnas.93.21.11341  0.456
1996 Ramsey-Ewing AL, Moss B. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene. Virology. 222: 75-86. PMID 8806489 DOI: 10.1006/Viro.1996.0399  0.493
1996 Cassetti MA, Moss B. Interaction of the 82-kDa subunit of the vaccinia virus early transcription factor heterodimer with the promoter core sequence directs downstream DNA binding of the 70-kDa subunit. Proceedings of the National Academy of Sciences of the United States of America. 93: 7540-5. PMID 8755510 DOI: 10.1073/Pnas.93.15.7540  0.355
1996 Senkevich TG, Bugert JJ, Sisler JR, Koonin EV, Darai G, Moss B. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science (New York, N.Y.). 273: 813-6. PMID 8670425 DOI: 10.1126/Science.273.5276.813  0.477
1996 Ramsey-Ewing A, Moss B. Recombinant protein synthesis in Chinese hamster ovary cells using a vaccinia virus/bacteriophage T7 hybrid expression system. The Journal of Biological Chemistry. 271: 16962-6. PMID 8663285 DOI: 10.1074/Jbc.271.28.16962  0.514
1996 Roper RL, Payne LG, Moss B. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. Journal of Virology. 70: 3753-62. PMID 8648710 DOI: 10.1128/Jvi.70.6.3753-3762.1996  0.55
1996 Wolffe EJ, Moore DM, Peters PJ, Moss B. Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis Journal of Virology. 70: 2797-2808. PMID 8627754 DOI: 10.1128/Jvi.70.5.2797-2808.1996  0.483
1996 Otteken A, Moss B. Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin. The Journal of Biological Chemistry. 271: 97-103. PMID 8550632 DOI: 10.1074/Jbc.271.1.97  0.436
1996 Rajagopal I, Ahn BY, Moss B, Mathews CK. Roles of vaccinia virus ribonucleotide reductase and glutaredoxin in DNA precursor biosynthesis. The Journal of Biological Chemistry. 270: 27415-8. PMID 7499196 DOI: 10.1074/Jbc.270.46.27415  0.496
1996 Bender BS, Rowe CA, Taylor SF, Wyatt LS, Moss B, Small PA. Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. Journal of Virology. 70: 6418-6424. DOI: 10.1128/jvi.70.9.6418-6424.1996  0.343
1996 Roper RL, Payne LG, Moss B. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. Journal of Virology. 70: 3753-3762. DOI: 10.1128/jvi.70.6.3753-3762.1996  0.37
1996 Hirsch VM, Fuerst TR, Sutter G, Carroll MW, Yang LC, Goldstein S, Piatak M, Elkins WR, Alvord WG, Montefiori DC, Moss B, Lifson JD. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. Journal of Virology. 70: 3741-3752. DOI: 10.1128/Jvi.70.6.3741-3752.1996  0.499
1996 Otteken A, Earl PL, Moss B. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates. Journal of Virology. 70: 3407-3415. DOI: 10.1128/Jvi.70.6.3407-3415.1996  0.384
1996 Wolffe EJ, Moore DM, Peters PJ, Moss B. Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis. Journal of Virology. 70: 2797-2808. DOI: 10.1128/jvi.70.5.2797-2808.1996  0.342
1996 Hu X, Carroll LJ, Wolffe EJ, Moss B. De novo synthesis of the early transcription factor 70-kilodalton subunit is required for morphogenesis of vaccinia virions. Journal of Virology. 70: 7669-7677. DOI: 10.1128/Jvi.70.11.7669-7677.1996  0.536
1995 Ramsey-Ewing A, Moss B. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis. Virology. 206: 984-93. PMID 7856109 DOI: 10.1006/Viro.1995.1021  0.491
1995 Wyatt LS, Moss B, Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells Virology. 210: 202-205. PMID 7793072 DOI: 10.1006/Viro.1995.1332  0.483
1995 Wolffe EJ, Vijaya S, Moss B. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology. 211: 53-63. PMID 7645236 DOI: 10.1006/Viro.1995.1378  0.41
1995 Ward GA, Stover CK, Moss B, Fuerst TR. Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 92: 6773-7. PMID 7624318 DOI: 10.1073/pnas.92.15.6773  0.426
1995 Blasco R, Moss B. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene. 158: 157-62. PMID 7607536 DOI: 10.1016/0378-1119(95)00149-Z  0.496
1995 Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, Moss B, Sette A, Chisari FV. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis Journal of Experimental Medicine. 181: 1047-1058. PMID 7532675 DOI: 10.1084/Jem.181.3.1047  0.428
1994 Sutter G, Ramsey-Ewing A, Rosales R, Moss B. Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant. Journal of Virology. 68: 4109-4116. PMID 8207789 DOI: 10.1128/Jvi.68.7.4109-4116.1994  0.534
1994 Rosales R, Sutter G, Moss B. A cellular factor is required for transcription of vaccinia viral intermediate-stage genes. Proceedings of the National Academy of Sciences of the United States of America. 91: 3794-8. PMID 8170989 DOI: 10.1073/Pnas.91.9.3794  0.499
1994 Machesky LM, Cole NB, Moss B, Pollard TD. Vaccinia virus expresses a novel profilin with a higher affinity for polyphosphoinositides than actin. Biochemistry. 33: 10815-24. PMID 8075084 DOI: 10.1021/Bi00201A032  0.419
1994 Rimmelzwaan GF, Siebelink KH, Huisman RC, Moss B, Francis MJ, Osterhaus AD. Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes. The Journal of General Virology. 75: 2097-102. PMID 8046415 DOI: 10.1099/0022-1317-75-8-2097  0.436
1994 Sutter G, Wyatt LS, Foley PL, Bennink JR, Moss B. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine. 12: 1032-40. PMID 7975844 DOI: 10.1016/0264-410X(94)90341-7  0.545
1994 Broder CC, Earl PL, Long D, Abedon ST, Moss B, Doms RW. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: Oligomer-specific and -sensitive monoclonal antibodies Proceedings of the National Academy of Sciences of the United States of America. 91: 11699-11703. PMID 7972127 DOI: 10.1073/Pnas.91.24.11699  0.377
1994 Moss B. Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development Developments in Biological Standardization. 82: 55-63. PMID 7958483  0.356
1994 Baldick CJ, Cassetti MC, Harris N, Moss B. Ordered assembly of a functional preinitiation transcription complex, containing vaccinia virus early transcription factor and RNA polymerase, on an immobilized template. Journal of Virology. 68: 6052-6056. DOI: 10.1128/Jvi.68.9.6052-6056.1994  0.343
1994 Kovacs GR, Rosales R, Keck JG, Moss B. Modification of the cascade model for regulation of vaccinia virus gene expression: purification of a prereplicative, late-stage-specific transcription factor. Journal of Virology. 68: 3443-3447. DOI: 10.1128/Jvi.68.5.3443-3447.1994  0.42
1994 Earl PL, Broder CC, Long D, Lee SA, Peterson J, Chakrabarti S, Doms RW, Moss B. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. Journal of Virology. 68: 3015-3026. DOI: 10.1128/jvi.68.5.3015-3026.1994  0.309
1994 Zhang Y, Ahn BY, Moss B. Targeting of a multicomponent transcription apparatus into assembling vaccinia virus particles requires RAP94, an RNA polymerase-associated protein. Journal of Virology. 68: 1360-1370. DOI: 10.1128/Jvi.68.3.1360-1370.1994  0.487
1994 Sodeik B, Griffiths G, Ericsson M, Moss B, Doms RW. Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65. Journal of Virology. 68: 1103-1114. DOI: 10.1128/jvi.68.2.1103-1114.1994  0.355
1993 Sodeik B, Doms RW, Ericsson M, Hiller G, Machamer CE, Van't Hof W, Van Meer G, Moss B, Griffiths G. Assembly of vaccinia virus: Role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks Journal of Cell Biology. 121: 521-542. PMID 8486734 DOI: 10.1083/Jcb.121.3.521  0.405
1993 Moss B. Poxvirus vectors: cytoplasmic expression of transferred genes Current Opinion in Genetics and Development. 3: 86-90. PMID 8453278 DOI: 10.1016/S0959-437X(05)80346-6  0.323
1993 Harris N, Rosales R, Moss B. Transcription initiation factor activity of vaccinia virus capping enzyme is independent of mRNA guanylylation. Proceedings of the National Academy of Sciences of the United States of America. 90: 2860-4. PMID 8385346 DOI: 10.1073/Pnas.90.7.2860  0.422
1993 Earl PL, Moss B. Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein. Aids Research and Human Retroviruses. 9: 589-94. PMID 8369163 DOI: 10.1089/Aid.1993.9.589  0.36
1993 Ashorn P, Berger EA, Moss B. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4. Methods in Enzymology. 221: 12-8. PMID 8361369 DOI: 10.1016/0076-6879(93)21004-R  0.404
1993 Yuwen H, Cox JH, Yewdell JW, Bennink JR, Moss B. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology. 195: 732-44. PMID 8337842 DOI: 10.1006/Viro.1993.1424  0.509
1993 Hügin AW, Flexner C, Moss B. Clearance of Recombinant Vaccinia Virus Expressing IL-2: Role of Local Host Immune Responses Cellular Immunology. 152: 499-509. PMID 8258152 DOI: 10.1006/Cimm.1993.1307  0.457
1993 Joklik WK, Moss B, Fields BN, Bishop DH, Sandakhchiev LS. Why the smallpox virus stocks should not be destroyed. Science (New York, N.Y.). 262: 1225-6. PMID 8235652 DOI: 10.1126/science.8235652  0.383
1993 Karacostas V, Wolffe EJ, Nagashima K, Gonda MA, Moss B. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology. 193: 661-71. PMID 7681610 DOI: 10.1006/Viro.1993.1174  0.464
1993 Wolffe EJ, Isaacs SN, Moss B. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. Journal of Virology. 67: 4732-4741. DOI: 10.1128/Jvi.67.8.4732-4741.1993  0.539
1993 Baldick CJ, Moss B. Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes. Journal of Virology. 67: 3515-3527. DOI: 10.1128/Jvi.67.6.3515-3527.1993  0.387
1993 Blasco R, Sisler JR, Moss B. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. Journal of Virology. 67: 3319-3325. DOI: 10.1128/Jvi.67.6.3319-3325.1993  0.508
1993 Keck JG, Kovacs GR, Moss B. Overexpression, purification, and late transcription factor activity of the 17-kilodalton protein encoded by the vaccinia virus A1L gene. Journal of Virology. 67: 5740-5748. DOI: 10.1128/Jvi.67.10.5740-5748.1993  0.451
1993 Gershon P, Moss B. Uridylate-containing RNA sequences determine specificity for binding and polyadenylation by the catalytic subunit of vaccinia virus poly(A) polymerase. The Embo Journal. 12: 4705-4714. DOI: 10.1002/J.1460-2075.1993.Tb06159.X  0.351
1992 Satchidanandam V, Zavala F, Moss B. Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei. Molecular and Biochemical Parasitology. 48: 89-99. PMID 1779992 DOI: 10.1016/0166-6851(91)90167-5  0.516
1992 Amegadzie BY, Sisler JR, Moss B. Frame-shift mutations within the vaccinia virus A-type inclusion protein gene. Virology. 186: 777-82. PMID 1733111 DOI: 10.1016/0042-6822(92)90046-R  0.482
1992 Isaacs SN, Kotwal GJ, Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence Proceedings of the National Academy of Sciences of the United States of America. 89: 628-632. PMID 1731333 DOI: 10.1073/Pnas.89.2.628  0.524
1992 Penna A, Fowler P, Bertoletti A, Guilhot S, Moss B, Margolskee RF, Cavalli A, Valli A, Fiaccadori F, Chisari FV. Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens. Journal of Virology. 66: 1193-8. PMID 1731098 DOI: 10.1128/Jvi.66.2.1193-1198.1992  0.417
1992 Rooney JF, Wohlenberg CR, Moss B, Notkins AL. Live vaccinia virus recombinants expressing herpes simplex virus genes. Reviews of Infectious Diseases. S898-903. PMID 1664124 DOI: 10.1093/Clind/13.Supplement_11.S898  0.507
1992 Moss B. Vaccinia virus vectors Biotechnology (Reading, Mass.). 20: 345-362. PMID 1600384 DOI: 10.1016/B978-0-7506-9265-6.50021-X  0.378
1992 Schnierle BS, Moss B. Vaccinia virus-mediated inhibition of host protein synthesis involves neither degradation nor underphosphorylation of components of the cap-binding eukaryotic translation initiation factor complex eIF-4F. Virology. 188: 931-3. PMID 1585660 DOI: 10.1016/0042-6822(92)90556-5  0.479
1992 Ahn BY, Moss B. RNA polymerase-associated transcription specificity factor encoded by vaccinia virus Proceedings of the National Academy of Sciences of the United States of America. 89: 3536-3540. PMID 1565650 DOI: 10.1073/Pnas.89.8.3536  0.489
1992 Zhang Y, Moss B. Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin. Virology. 187: 643-53. PMID 1546459 DOI: 10.1016/0042-6822(92)90467-4  0.528
1992 Adams LD, Tomasselli AG, Robbins P, Moss B, Heinrikson RL. HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. Aids Research and Human Retroviruses. 8: 291-5. PMID 1540415 DOI: 10.1089/Aid.1992.8.291  0.382
1992 Merchlinsky M, Moss B. Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination-independent selectable cloning vectors. Virology. 190: 522-6. PMID 1529553 DOI: 10.1016/0042-6822(92)91246-Q  0.437
1992 Ashorn P, Moss B, Berger EA. Therapeutic strategies employing CD4, the HIV receptor. Advances in Experimental Medicine and Biology. 312: 71-81. PMID 1514446 DOI: 10.1007/978-1-4615-3462-4_6  0.339
1992 Ahn BY, Moss B. Glutaredoxin homolog encoded by vaccinia virus is a virion-associated enzyme with thioltransferase and dehydroascorbate reductase activities Proceedings of the National Academy of Sciences of the United States of America. 89: 7060-7064. PMID 1496000 DOI: 10.1073/Pnas.89.15.7060  0.486
1992 Sutter G, Moss B. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proceedings of the National Academy of Sciences of the United States of America. 89: 10847-51. PMID 1438287 DOI: 10.1073/Pnas.89.22.10847  0.511
1992 Isaacs SN, Wolffe EJ, Payne LG, Moss B. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. Journal of Virology. 66: 7217-24. PMID 1433514 DOI: 10.1128/Jvi.66.12.7217-7224.1992  0.517
1992 McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM. Regulation of complement activity by vaccinia virus complement-control protein. The Journal of Infectious Diseases. 166: 1245-50. PMID 1431243 DOI: 10.1093/Infdis/166.6.1245  0.474
1992 Moss B. Vaccinia and other poxvirus expression vectors Current Opinion in Biotechnology. 3: 518-522. PMID 1368937 DOI: 10.1016/0958-1669(92)90080-3  0.479
1992 Gershon PD, Moss B. Transition from rapid processive to slow nonprocessive polyadenylation by vaccinia virus poly(A) polymerase catalytic subunit is regulated by the net length of the poly(A) tail. Genes & Development. 6: 1575-86. PMID 1353739 DOI: 10.1101/Gad.6.8.1575  0.4
1992 Morgan RA, Couture L, Elroy-Stein O, Ragheb J, Moss B, Anderson WF. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Research. 20: 1293-9. PMID 1313966 DOI: 10.1093/Nar/20.6.1293  0.382
1992 Schnierle BS, Gershon PD, Moss B. Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein. Proceedings of the National Academy of Sciences of the United States of America. 89: 2897-901. PMID 1313572 DOI: 10.1073/Pnas.89.7.2897  0.426
1992 Baldick CJ, Keck JG, Moss B. Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters. Journal of Virology. 66: 4710-4719. DOI: 10.1128/Jvi.66.8.4710-4719.1992  0.383
1992 Amegadzie BY, Ahn BY, Moss B. Characterization of a 7-kilodalton subunit of vaccinia virus DNA-dependent RNA polymerase with structural similarities to the smallest subunit of eukaryotic RNA polymerase II. Journal of Virology. 66: 3003-3010. DOI: 10.1128/Jvi.66.5.3003-3010.1992  0.411
1992 Ahn BY, Rosel J, Cole NB, Moss B. Identification and expression of rpo19, a vaccinia virus gene encoding a 19-kilodalton DNA-dependent RNA polymerase subunit. Journal of Virology. 66: 971-982. DOI: 10.1128/Jvi.66.2.971-982.1992  0.494
1992 Isaacs SN, Wolffe EJ, Payne LG, Moss B. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. Journal of Virology. 66: 7217-7224. DOI: 10.1128/jvi.66.12.7217-7224.1992  0.388
1992 Zhang Y, Keck JG, Moss B. Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus. Journal of Virology. 66: 6470-6479. DOI: 10.1128/Jvi.66.11.6470-6479.1992  0.505
1991 Ashorn P, Moss B, Berger EA. Anti-HIV effects of CD4-Pseudomonas exotoxin on human lymphocyte and monocyte/macrophage cell lines. Annals of the New York Academy of Sciences. 616: 149-54. PMID 2078015 DOI: 10.1111/J.1749-6632.1990.Tb17835.X  0.31
1991 Moss B. Vaccinia virus: A tool for research and vaccine development Science. 252: 1662-1667. PMID 2047875 DOI: 10.1126/Science.2047875  0.444
1991 Wright CF, Keck JG, Tsai MM, Moss B. A transcription factor for expression of vaccinia virus late genes is encoded by an intermediate gene. Journal of Virology. 65: 3715-20. PMID 2041091 DOI: 10.1128/Jvi.65.7.3715-3720.1991  0.494
1991 Ashorn P, Englund G, Martin MA, Moss B, Berger EA. Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages. The Journal of Infectious Diseases. 163: 703-9. PMID 2010626 DOI: 10.1093/Infdis/163.4.703  0.333
1991 Kaslow DC, Isaacs SN, Quakyi IA, Gwadz RW, Moss B, Keister DB. Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. Science (New York, N.Y.). 252: 1310-3. PMID 1925544 DOI: 10.1126/Science.1925544  0.413
1991 Zhang YF, Moss B. Inducer-dependent conditional-lethal mutant animal viruses. Proceedings of the National Academy of Sciences of the United States of America. 88: 1511-5. PMID 1899929 DOI: 10.1073/Pnas.88.4.1511  0.483
1991 Zibert A, Selinka HC, Elroy-Stein O, Moss B, Wimmer E. Vaccinia virus-mediated expression and identification of the human poliovirus receptor. Virology. 182: 250-9. PMID 1850905 DOI: 10.1016/0042-6822(91)90668-2  0.491
1991 Amegadzie BY, Holmes MH, Cole NB, Jones EV, Earl PL, Moss B. Identification, sequence, and expression of the gene encoding the second-largest subunit of the vaccinia virus DNA-dependent RNA polymerase. Virology. 180: 88-98. PMID 1824607 DOI: 10.1016/0042-6822(91)90012-Z  0.461
1991 Doms RW, Earl PL, Moss B. The assembly of the HIV-1 env glycoprotein into dimers and tetramers Advances in Experimental Medicine and Biology. 300: 203-221. PMID 1781345 DOI: 10.1007/978-1-4684-5976-0_13  0.385
1991 Takahashi K, Dai LIC, Fuerst TR, Biddison WE, Earl PL, Moss B, Ennis FA. Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein Proceedings of the National Academy of Sciences of the United States of America. 88: 10277-10281. PMID 1719555 DOI: 10.1073/Pnas.88.22.10277  0.454
1991 Littaua RA, Oldstone MB, Takeda A, Debouck C, Wong JT, Tuazon CU, Moss B, Kievits F, Ennis FA. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. Journal of Virology. 65: 4051-6. PMID 1712857 DOI: 10.1128/Jvi.65.8.4051-4056.1991  0.397
1991 Ashorn P, Moss B, Weinstein JN, Chaudhary VK, FitzGerald DJ, Pastan I, Berger EA. Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 87: 8889-93. PMID 1701055 DOI: 10.1073/Pnas.87.22.8889  0.395
1991 Gershon PD, Ahn BY, Garfield M, Moss B. Poly(A) polymerase and a dissociable polyadenylation stimulatory factor encoded by vaccinia virus. Cell. 66: 1269-78. PMID 1670500 DOI: 10.1016/0092-8674(91)90048-4  0.422
1991 Blasco R, Cole NB, Moss B. Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein. Journal of Virology. 65: 4598-4608. DOI: 10.1128/Jvi.65.9.4598-4608.1991  0.559
1991 Earl PL, Moss B, Doms RW. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. Journal of Virology. 65: 2047-2055. DOI: 10.1128/jvi.65.4.2047-2055.1991  0.311
1991 Zhang YF, Moss B. Vaccinia virus morphogenesis is interrupted when expression of the gene encoding an 11-kilodalton phosphorylated protein is prevented by the Escherichia coli lac repressor. Journal of Virology. 65: 6101-6110. DOI: 10.1128/jvi.65.11.6101-6110.1991  0.356
1991 Blasco R, Moss B. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. Journal of Virology. 65: 5910-5920. DOI: 10.1128/jvi.65.11.5910-5920.1991  0.428
1991 Earl PL, Koenig S, Moss B. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. Journal of Virology. 65: 31-41. DOI: 10.1128/jvi.65.1.31-41.1991  0.407
1990 Davison AJ, Moss B. Structure of vaccinia virus late promoters. Journal of Molecular Biology. 210: 771-84. PMID 2515287 DOI: 10.1016/0022-2836(89)90108-3  0.406
1990 Berger EA, Clouse KA, Chaudhary VK, Chakrabarti S, FitzGerald DJ, Pastan I, Moss B. CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses. Proceedings of the National Academy of Sciences of the United States of America. 86: 9539-43. PMID 2480605 DOI: 10.1073/pnas.86.23.9539  0.305
1990 Takahashi H, Houghten R, Putney SD, Margulies DH, Moss B, Germain RN, Berzofsky JA. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. The Journal of Experimental Medicine. 170: 2023-35. PMID 2479705 DOI: 10.1084/Jem.170.6.2023  0.319
1990 McQuade TJ, Tomasselli AG, Liu L, Karacostas V, Moss B, Sawyer TK, Heinrikson RL, Tarpley WG. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science (New York, N.Y.). 247: 454-6. PMID 2405486 DOI: 10.1126/Science.2405486  0.338
1990 Ahn BY, Gershon PD, Jones EV, Moss B. Identification of rpo30, a vaccinia virus RNA polymerase gene with structural similarity to a eucaryotic transcription elongation factor. Molecular and Cellular Biology. 10: 5433-41. PMID 2398897 DOI: 10.1128/Mcb.10.10.5433  0.471
1990 Davison AJ, Moss B. New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Nucleic Acids Research. 18: 4285-6. PMID 2377486 DOI: 10.1093/Nar/18.14.4285  0.469
1990 Keck JG, Baldick CJ, Moss B. Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes. Cell. 61: 801-9. PMID 2344616 DOI: 10.1016/0092-8674(90)90190-P  0.427
1990 Flexner C, Moss B, London WT, Murphy BR. Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2 Vaccine. 8: 17-21. PMID 2316280 DOI: 10.1016/0264-410X(90)90171-H  0.401
1990 Earl PL, Doms RW, Moss B. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein Proceedings of the National Academy of Sciences of the United States of America. 87: 648-652. PMID 2300552 DOI: 10.1073/Pnas.87.2.648  0.304
1990 Moss B. Regulation of orthopoxvirus gene expression Current Topics in Microbiology and Immunology. 163: 41-70. PMID 2242681  0.336
1990 Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science (New York, N.Y.). 250: 827-30. PMID 2237434 DOI: 10.1126/Science.2237434  0.513
1990 Moss B, Elroy-Stein O, Mizukami T, Alexander WA, Fuerst TR. Product review. New mammalian expression vectors. Nature. 348: 91-2. PMID 2234068 DOI: 10.1038/348091A0  0.35
1990 Isaacs SN, Kotwal GJ, Moss B. Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses Virology. 178: 626-630. PMID 2219714 DOI: 10.1016/0042-6822(90)90367-Z  0.523
1990 Ashorn P, McQuade TJ, Thaisrivongs S, Tomasselli AG, Tarpley WG, Moss B. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proceedings of the National Academy of Sciences of the United States of America. 87: 7472-6. PMID 2217178 DOI: 10.1073/Pnas.87.19.7472  0.406
1990 Elroy-Stein O, Moss B. Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 87: 6743-6747. PMID 2204064 DOI: 10.1073/Pnas.87.17.6743  0.4
1990 Moss B. Regulation of vaccinia virus transcription Annual Review of Biochemistry. 59: 661-688. PMID 2197987 DOI: 10.1146/Annurev.Bi.59.070190.003305  0.432
1990 Gershon PD, Moss B. Early transcription factor subunits are encoded by vaccinia virus late genes. Proceedings of the National Academy of Sciences of the United States of America. 87: 4401-5. PMID 2190222 DOI: 10.1073/Pnas.87.11.4401  0.458
1990 Shuman S, Moss B. Purification and use of vaccinia virus messenger RNA capping enzyme Methods in Enzymology. 181: 170-180. PMID 2166212 DOI: 10.1016/0076-6879(90)81119-F  0.322
1990 Guo P, Moss B. Interaction and mutual stabilization of the two subunits of vaccinia virus mRNA capping enzyme coexpressed in Escherichia coli Proceedings of the National Academy of Sciences of the United States of America. 87: 4023-4027. PMID 2161527 DOI: 10.1073/Pnas.87.11.4023  0.346
1990 Moss B. Recombinant DNA virus vectors for vaccination Seminars in Immunology. 2: 317-327. PMID 2134016  0.401
1990 Chakrabarti S, Mizukami T, Franchini G, Moss B. Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus. Virology. 178: 134-42. PMID 2117828 DOI: 10.1016/0042-6822(90)90386-6  0.455
1990 Berger EA, Chaudhary VK, Clouse KA, Jaraquemada D, Nicholas JA, Rubino KL, Fitzgerald DJ, Pastan I, Moss B. Recombinant CD4-Pseudomonas exotoxin hybrid protein displays HIV-specific cytotoxicity without affecting MHC class II-dependent functions Aids Research and Human Retroviruses. 6: 795-804. PMID 2114147 DOI: 10.1089/Aid.1990.6.795  0.345
1990 Pantaleo G, De Maria A, Koenig S, Butini L, Moss B, Baseler M, Lane HC, Fauci AS. CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 87: 4818-22. PMID 2112749 DOI: 10.1073/Pnas.87.12.4818  0.307
1990 Polydefkis M, Koenig S, Flexner C, Obah E, Gebo K, Chakrabarti S, Earl PL, Moss B, Siliciano RF. Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition Journal of Experimental Medicine. 171: 875-887. PMID 1968506 DOI: 10.1084/Jem.171.3.875  0.31
1990 Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, Kanagawa O, Chisari FV. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science (New York, N.Y.). 248: 361-4. PMID 1691527 DOI: 10.1126/Science.1691527  0.388
Show low-probability matches.